{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 8192,
        "quantization": "bitsandbytes",
        "gpu_memory_utilization": 0.7,
        "enforce_eager": true,
        "limit_mm_per_prompt": {
          "image": 0
        }
      },
      "model": {
        "name": "google/medgemma-4b-it",
        "variant": "4b",
        "max_new_tokens": 512,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_4b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.tcga.TCGAPromptStrategy",
        "name": "tcga",
        "few_shot": true,
        "answer_first": true,
        "contrarian": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.loaders.TCGADataset",
        "name": "tcga",
        "reports_filename": "tcga/TCGA_Reports.csv",
        "labels_filename": "tcga/tcga_patient_to_cancer_type.csv",
        "split": "test"
      },
      "experiment": {
        "_target_": "cotlab.experiments.ClassificationExperiment",
        "name": "classification",
        "description": "Classification from medical reports",
        "num_samples": 20
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-24T13:26:27.951287"
  },
  "experiment": "classification",
  "model": "google/medgemma-4b-it",
  "prompt_strategy": "tcga",
  "metrics": {
    "correct": 6,
    "incorrect": 14,
    "parse_errors": 0,
    "accuracy": 0.3,
    "parse_error_rate": 0.0,
    "classification_report": {
      "BLCA": {
        "precision": 1.0,
        "recall": 0.3333333333333333,
        "f1-score": 0.5,
        "support": 3.0
      },
      "BRCA": {
        "precision": 1.0,
        "recall": 0.3333333333333333,
        "f1-score": 0.5,
        "support": 3.0
      },
      "CCRC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 0.0
      },
      "CESC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "COAD": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "HNSC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 3.0
      },
      "KICH": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "KIRC": {
        "precision": 0.5,
        "recall": 1.0,
        "f1-score": 0.6666666666666666,
        "support": 1.0
      },
      "LUAD": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 0.0
      },
      "LUSC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "PCPG": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 0.0
      },
      "PRAD": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "SARC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "SCC": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 0.0
      },
      "STAD": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 1.0
      },
      "THCA": {
        "precision": 1.0,
        "recall": 1.0,
        "f1-score": 1.0,
        "support": 1.0
      },
      "THYM": {
        "precision": 1.0,
        "recall": 1.0,
        "f1-score": 1.0,
        "support": 1.0
      },
      "UCEC": {
        "precision": 1.0,
        "recall": 1.0,
        "f1-score": 1.0,
        "support": 1.0
      },
      "UROS": {
        "precision": 0.0,
        "recall": 0.0,
        "f1-score": 0.0,
        "support": 0.0
      },
      "accuracy": 0.3,
      "macro avg": {
        "precision": 0.2894736842105263,
        "recall": 0.24561403508771926,
        "f1-score": 0.24561403508771926,
        "support": 20.0
      },
      "weighted avg": {
        "precision": 0.475,
        "recall": 0.3,
        "f1-score": 0.3333333333333333,
        "support": 20.0
      }
    },
    "macro_precision": 0.2894736842105263,
    "macro_recall": 0.24561403508771926,
    "macro_f1": 0.24561403508771926,
    "weighted_f1": 0.3333333333333333,
    "confusion_matrix": [
      [
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        2
      ],
      [
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        2,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        2,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        1,
        0
      ],
      [
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ]
    ],
    "class_labels": [
      "BLCA",
      "BRCA",
      "CCRC",
      "CESC",
      "COAD",
      "HNSC",
      "KICH",
      "KIRC",
      "LUAD",
      "LUSC",
      "PCPG",
      "PRAD",
      "SARC",
      "SCC",
      "STAD",
      "THCA",
      "THYM",
      "UCEC",
      "UROS"
    ],
    "top_confused_pairs": [
      [
        "BLCA",
        "UROS",
        2
      ],
      [
        "BRCA",
        "LUAD",
        2
      ],
      [
        "HNSC",
        "LUAD",
        2
      ],
      [
        "CESC",
        "CCRC",
        1
      ],
      [
        "COAD",
        "LUAD",
        1
      ],
      [
        "HNSC",
        "SCC",
        1
      ],
      [
        "KICH",
        "KIRC",
        1
      ],
      [
        "LUSC",
        "LUAD",
        1
      ],
      [
        "PRAD",
        "PCPG",
        1
      ],
      [
        "SARC",
        "PRAD",
        1
      ]
    ],
    "true_class_distribution": {
      "THYM": 1,
      "CESC": 1,
      "BLCA": 3,
      "KIRC": 1,
      "KICH": 1,
      "HNSC": 3,
      "COAD": 1,
      "BRCA": 3,
      "UCEC": 1,
      "SARC": 1,
      "STAD": 1,
      "LUSC": 1,
      "PRAD": 1,
      "THCA": 1
    },
    "pred_class_distribution": {
      "THYM": 1,
      "CCRC": 1,
      "UROS": 2,
      "KIRC": 2,
      "SCC": 1,
      "LUAD": 7,
      "BRCA": 1,
      "UCEC": 1,
      "PRAD": 1,
      "BLCA": 1,
      "PCPG": 1,
      "THCA": 1
    },
    "num_classes": 19
  },
  "raw_outputs": [
    {
      "sample_idx": 1309,
      "input": "Macroscopic examination : Piece weighing 1208 g thymectomy fresh and measuring 19 x 17 x 8 cm. it. extended by a pulmonary resection lingula measuring 8 X 5 X 2 cm When cut , it. is a yellowish white tumor lobulated showing necrotic and remodeling. a small yellowish nodule. Lymph node latero- tracheal top right measuring 1.5 cm in diameter. Microscopic examination : 1) Thymectomy : Many samples were taken ( 1A to 1D ) The tumor has an architecture. lobulated It comprises an epithelial cell proli...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMacroscopic examination : Piece weighing 1208 g thymectomy fresh and measuring 19 x 17 x 8 cm. it. extended by a pulmonary resection lingula measuring 8 X 5 X 2 cm When cut , it. is a yellowish white tumor lobulated showing necrotic and remodeling. a small yellowish nodule. Lymph node latero- tracheal top right measuring 1.5 cm in diameter. Microscopic examination : 1) Thymectomy : Many samples were taken ( 1A to 1D ) The tumor has an architecture. lobulated It comprises an epithelial cell proliferation primarily. fusiform These cells are grouped together in small bundles . They are arranged. also small beaches. Lymphocyte contigent is also abundant enough. mixed with epithelial contigent. Presence of some beaches fibrosis with remodeling. inflammatory with tablecloths foamy histiocytes . No outbreak of differentiation. medulla. Presence of a range of tumor necrosis Presence of some clear spaces. perivascular (1B) . The tumor is highly infiltrative and invades the lung parenchyma. (1E) The limits of resection inked in green appear microscopically healthy. Some areas appear much richer in epithelial cells with a. scarcity of accompanying lymphocytes. After immunohistochemistry epithelial cells express cytokeratin KL1. and focally CD20. However, they are negative for CD5 and CD117. 2) Lymph node lat\u00e9rotrach\u00e9al top right : This is a little modified lymph node No histological evidence of. malignancy. Conclusion : Type AB thymoma in 19 cm major axis , with widely invasive invasion in the. lung parenchyma stage 3 according to the classification of Masaoka resection. surgical complete.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA",
      "predicted": "THYM",
      "ground_truth": "THYM",
      "correct": true,
      "reasoning": "Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.",
      "idx": 1309,
      "timestamp": "2026-01-24T13:29:56.318934"
    },
    {
      "sample_idx": 228,
      "input": "Result date: Date Collected: SPECIMEN A: CERVIX BX. SPECIMEN B: BLADDER BX. CLINICAL HISTORY: SPECIMENS SUBMITTED: A. CERVIX BX. B. BLADDER BX. DIAGNOSIS: CERVIX; BIOPSY: INVASIVE, POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. ANGIOLYMPHATIC INVASION NOT IDENTIFIED. SPECIMEN IS NEARLY ENTIRELY INVASIVE CARCINOMA, DEPTH OF INVASION CANNOT BE. DETERMINED, BUT TUMOR MEASURES 1.0 CM IN MICROSCOPIC SECTION. BLADDER, BIOPSY: SQUAMOUS METAPLASIA WITHOUT DYSPLASIA. NEGATIVE FOR CARCINOMA. ABUNDANT BLOO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nResult date: Date Collected: SPECIMEN A: CERVIX BX. SPECIMEN B: BLADDER BX. CLINICAL HISTORY: SPECIMENS SUBMITTED: A. CERVIX BX. B. BLADDER BX. DIAGNOSIS: CERVIX; BIOPSY: INVASIVE, POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. ANGIOLYMPHATIC INVASION NOT IDENTIFIED. SPECIMEN IS NEARLY ENTIRELY INVASIVE CARCINOMA, DEPTH OF INVASION CANNOT BE. DETERMINED, BUT TUMOR MEASURES 1.0 CM IN MICROSCOPIC SECTION. BLADDER, BIOPSY: SQUAMOUS METAPLASIA WITHOUT DYSPLASIA. NEGATIVE FOR CARCINOMA. ABUNDANT BLOOD CLOT WITH EXFOLIATED BUT BENIGN APPEARING EPITHELIAL CELLS. BIOPSY CONTAINS NO MUSCLE CONSISTENT WITH MUSCULARIS PROPRIA. I. INTRA-OPERATIVE DIAGNOSIS: Cervical biopsy: Invasive squamous cell carcinoma. CLINICAL INFORMATION: -year old female with large cervical lesion consistent with cervical. cancer. GROSS DESCRIPTION: There are two containers, each labeled with the patient's name and medical. record number. Rendering Diagnostician: Completed Action List:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BL",
      "predicted": "CCRC",
      "ground_truth": "CESC",
      "correct": false,
      "reasoning": "Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.",
      "idx": 228,
      "timestamp": "2026-01-24T13:29:56.318959"
    },
    {
      "sample_idx": 51,
      "input": "SURGICAL PATHOL 03Y REPOR. DIAGNOSIS: RADICAL CYSTOPROSTATECTOMY, BILATERAL PELVIC LYMPH NODE DISSECTION AND. URINARY DIVERSION (T-POUCH) : RIGHT DISTAL URETER (A) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT DISTAL URETER (B) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. - NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. PARA-AO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSURGICAL PATHOL 03Y REPOR. DIAGNOSIS: RADICAL CYSTOPROSTATECTOMY, BILATERAL PELVIC LYMPH NODE DISSECTION AND. URINARY DIVERSION (T-POUCH) : RIGHT DISTAL URETER (A) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT DISTAL URETER (B) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. - NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. PARA-AORTIC PROXIMAL LIMITS LYMPH NODES (C) : FROZEN SECTION DIAGNOSIS: - BENIGN. FINAL DIAGNOSIS: - NO MALIGNANCY IDENTIFIED IN TWO LYMPH NODES EXAMINED (0/2). APICAL URETHRAL MARGIN (D) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: - SCANT MALIGNANT CELLS IN PERIPHERAL SOFT TISSUE OF URETHRA (SEE COMMENT). BENIGN URETHRAL MUCOSA. BLADDER AND PROSTATE (E) : BLADDER: - INVASIVE POORLY DIFFERENTIATED UROTHELIAL CARCINOMA WITH FOCAL SIGNET. RING CELL COMPONENT (3.! X 3.0 x 2.2 CM GROSS DIMENSIONS), , GRADE 4/4, GROSSLY. AND MICROSCOPICALLY EXTENDING THROUGH ANTERIOR AND RIGHT AND LEFT. LATERAL BLADDER WALLS TO INVOLVE PERIVESICAL SOFT TISSUE. LYMPHOVASCULAR INVASION IDENTIFIED. - UROTHELIAL CARCINOMA IN SITU (FLAT LESION) IDENTIFIED INCLUDING PAGETOID. INVOLVEMENT OF TRIGONE. - RANDOM BLADDER MUCOSA EXHIBITING FOCI OF MODERATE UROTHELIAL DYSPLASIA. AND REACTIVE ATYPIA. INKED BLADDER RESECTION MARGINS, FREE OF MALIGNANCY. PROSTATE: - INVASIVE UROTHELIAL CARCINOMA INVOLVING PERIPROSTATIC SOFT TISSUE OF ENTIRE. PROSTATE, WITH INVASION OF PROSTATIC STROMA AND LYMPHOVASCULAR SPACE. INVOLVEMENT. - INVASIVE UROTHELIAL CARCINOMA INVOLVING SOFT TISSUE AROUND SEMINAL. VESICLES. - UROTHELIAL CARCINOMA INVOLVING INKED RIGHT POSTERIOR PERIPROSTATIC. SOFT TISSUE MARGIN. RARE FOCI OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN II). NO PROSTATIC ADENOCARCINOMA IDENTIFIED. RIGHT PARACAVAL LYMPH NODES (F) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF THREE LYMPH NODES EXAMINED. (3/3). SURGICALPATHOLOG REPORT. LEFT PARA-AORTIC LYMPH NODES (G) : METASTATIC CARCINOMA IDENTIFIED IN ONE OF THREE LYMPH NODES EXAMINED (1/3). RIGHT COMMON ILIAC LYMPH NODES (H) : METASTATIC CARCINOMA IDENTIFIED IN TWO OF TWO LYMPH NODES EXAMINED. (2/2). LEFT COMMON ILIAC LYMPH NODES (I) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF SEVEN LYMPH NODES EXAMINED. RIGHT LYMPH NODES OF CLOQUET (J) : NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE EXAMINED (0/1). RIGHT EXTERNAL ILIAC LYMPH NODES (K) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF FOUR LYMPH NODES EXAMINED. (3/4) [LARGEST POSITIVE LYMPH NODE 2.9 CM]. RIGHT OBTURATOR/HYPOGASTRIC LYMPH NODES (L) : METASTATIC CARCINOMA IDENTIFIED IN SIX OF NINE LYMPH NODES EXAMINED (5/8). LEFT EXTERNAL ILIAC LYMPH NODES (M) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF SEVEN LYMPH NODES EXAMINED (2/7). LEFT LYMPH NODE OF CLOQUET (N) : NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE EXAMINED (0/1). LEFT OBTURATOR/HYPOGASTRIC LYMPH NODES (O) : METASTATIC CARCINOMA IDENTIFIED IN FOUR OF FOUR LYMPH NODES EXAMINED (4/4). RIGHT PRESCIATIC LYMPH NODES (P) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF THREE LYMPH NODES EXAMINED. (3/3). PRESACRAL LYMPH NODES (Q) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF FOUR LYMPH NODES EXAMINED (2/4). LEFT PRESCIATIC LYMPH NODES (R) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF FOUR LYMPH NODES EXAMINED (2/4). RIGHT PROXIMAL URETER (S) : - BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT PROXIMAL URETER (T) : BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LYMPH NODE SUMMARY: METASTATIC CARCINOMA IDENTIFIED IN TOTAL OF 30 OUT. 53 LYMPH NODES EXAMINED (30/53). PATHOLOGIC TNM STAGE: pT4aN2MX. Verified: COMMENT: Dr. was notified of the disprepancy in the frozen section diagnosis and. final diagnosis for the apical urethral margin,. SPECIMEN SOURCE: A: \" Right distal ureter\". B: \"Left distal ureter\". C: \"Para aortic proximal limits lymph nodes - FS\". D: \"Apical urethral margin\". E: \"Bladder + prostate\". F: \"Right para caval lymph nodes\". G: \"Left para aortic lymph nodes\". H: \"Right common iliac lymph nodes\". I: \"Left common iliac lymph nodes\". J: \"Right lymph nodes of cloquet\". K: \"Right external iliac lymph nodes\". L: \"Right obturator/hypogastrio lymph nodes\". M: \"Left external iliac lymph nodes\". N: \"Left lymph node of cloquet\". O: \"left obturator/hypogastric lymph nodes\". P: \"Right pre sciatic lymph nodes\". Q: \"Pre sacral lymph nodes\". R: \"Left pre sciatic lymph nodes\". S: \"Right proximal ureter\". T: \"Left proximal ureter\". CLINICAL INFORMATION: Pre-Op Dx: Bladder cancer, TCC. GROSS EXAMINATION: A: The specimen is received fresh from the O.R. and labeled \"Right distal ureter\". It consists of a segment of ureter measuring 0.4 cm in length by 0.2 cm in. diameter. The specimen is submitted entirely for frozen section in cassette AFS. B: The specimen is received fresh from the O.R. and labeled \"Left distal ureter\". It consists of a segment of ureter measuring 0.4 cm in length by 0.2 cm in. diameter. The specimen is submitted entirely for frozen section in cassette BFS. C: The specimen is received fresh from the O.R. and labeled \"Para aortic proximal. limits lymph nodes - FS\". It consists of a segment of soft tan-yellow adipose. tissue measuring 2 x 1.1 x 0.8 cm. Multiple lymph nodes are identified and. submitted entirely for frozen section in cassette CFS. D: The specimen is received fresh from the O.R. and labeled \"Apical urethral. margin\". It consists of two fragments of soft tan-pink tissue measuring in. aggregate 1.4 x 0.4 x 0.4 cm. The specimen is submitted entirely for frozen. section in cassette DFS. E: The specimen is received fresh from the O.R. and labeled \"Bladder + prostate\". It consists of a cystoprostatectomy specimen measuring overall 14 x 10.5 x 4.8 cm. The peritoneum measures 15 x 11 x 0.1 cm and is smooth, glistening and freely. mobile. The non-peritonealized surface is inked black with red ink superimposed. over the right side of the prostate. The specimen is opened anteriorly along the. prostatic urethra. The bladder measures 6 x 4 x 3.5 cm with a wall thickness of. 0.8 cm. The bilateral ureterovesical junctions are identified and are patent. The. ureters are then opened. The right attached ureter measures 5 cm in length by 0.5. cm in circumference and the left attached ureter measures 4 cm in length by 0.5 cm. in circumference. Both the right and left ureters are grossly unremarkable. The. CHDATAR DATEA thav REPORT. Gollected. anterior wall of the bladder is replaced by a tan-red, firm and ulcerated mass. that extends from the anterior wall to both the right and left lateral aspects of. the bladder while sparing the ureterovesical junctions and trigone area. This mass. measures 3.5 x 3 x 2.2 cm and appears to grossly involve the full thickness of the. bladder wall with gross extension into the perivesical fat anteriorly and on both. the right and left aspects of the bladder. The wall thickness of the involved. bladder measures 2.2 cm. The remaining bladder mucosa is tan-pink and slightly. edematous. The prostate measures 4 x 3.5 x 3.5 cm. The prostatic urethra measures. 3 cm in length by 2 cm in circumference and is grossly unremarkable. The. verumontanum measures 1 x 0.3 x 0.3 cm. The right seminal vesicle measures 3 x 1.5. x 1 cm, and the left seminal vesicle measures 3 x 1.5 x 1 cm. Both the seminal. vesicles are grossly unremarkable. Palpating the perivesical fat shows no. additional nodules. Representative sections are submitted in 27 cassettes. F: The specimen is received in formalin and labeled \"Right para caval lymph. nodes\" It consists of a segment of soft tan-yellow fibroadipose tissue measuring. 4. x 2 x 1 cm. Two lymph nodes are identified, the largest measuring 2 cm in. greatest dimension. The specimen is submitted entirely in three cassettes. G: The specimen is received in formalin and labeled \"Left para aortic lymph. nodes\". It consists of a single segment of soft tan-yellow fibroadipose tissue. measuring 3.5 x 1 x 1 cm. One lymph node is identified measuring 1 cm in greatest. dimension. The specimen is submitted entirely in one cassette. H: The specimen is received in formalin and labeled \"Right common iliac lymph. nodes\" It consists of two segments of soft tan-yellow fibroadipose tissue. measuring in aggregate 6 x 3 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 3.8 cm in greatest dimension. The specimen is submitted entirely. in six cassettes. I: The specimen is received in formalin and labeled \"Left common iliac lymph. nodes\" It consists of multiple segments of soft tan-yellow fibroadipose tissue. measuring 4 x 1.5 x 2 cm in aggregate. Multiple lymph nodes are identified, the. largest measuring 1.8 cm in greatest dimension. The specimen is submitted entirely. in three cassettes. J: The specimen is received in formalin and labeled \"Right lymph nodes of. cloquet\" It consists of a single segment of soft tan-yellow fibroadipose tissue. measuring 2 x 1.1 x 0.7 cm. One lymph node is identified measuring 1.5 cm in. greatest dimension. The specimen is bisected and submitted entirely in one. cassette. K: The specimen is received in formalin and labeled \"Right external iliac lymph. nodes\". It consists of multiple segments of soft tan-yellow fibroadipose tissue. measuring in aggregate 5 x 3.5 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 3 cm in greatest dimension. The specimen is submitted entirely. in six cassettes. L: The specimen is received in formalin and labeled \"Right obturator/hypogastric. lymph nodes\" It consists of multiple segments of soft tan-yellow fibroadipose. tissue measuring in aggregate 6.5 x 4 x 2 cm. Multiple lymph nodes are identified,. the largest measuring 4 cm in greatest dimension. The specimen is submitted. entirely in eight cassettes. M: The specimen is received in formalin and labeled \"Left external iliac lymph. nodes\". It consists of multiple pieces of soft tan-yellow fibroadipose tissue. measuring in aggregate 4 x 3 x 3 cm. Multiple lymph nodes are identified, the. largest measuring 2 cm in greatest dimension. The specimen is submitted entirely. in seven cassettes. colected. N: The specimen is received in formalin and labeled \"Left lymph node of cloquet\". It consists of a single segment of tan-yellow fibroadipose tissue measuring 1.5 x 1. x 0.8 cm. One lymph node is identified measuring 1.3 cm in greatest dimension. The specimen is submitted entirely in one cassette. O: The specimen is received in formalin and labeled \"left obturator/hypogastrio. lymph nodes\". It consists of multiple segments of soft tan-yellow fibroadipose. tissue measuring in aggregate 6 x 3 x 1 cm. Multiple lymph nodes are identified,. the largest measuring 4.6 cm in greatest dimension. The specimen is submitted. entirely in six cassettes. P: The specimen is received in formalin and labeled \"Right pre sciatic lymph. nodes\" It consists of multiple fragments of soft tan-yellow fibroadipose tissue. measuring in aggregate 2 x 1 x 0.6 cm. Two lymph nodes are identified, the largest. measuring 0.5 cm in greatest dimension. The specimen is submitted entirely in one. cassette. Q: The specimen is received in formalin and labeled \"Pre sacral lymph nodes\". It. consists of a single piece of soft tan-pink fibroadipose tissue measuring 4.8 x 2.5. x 0.8 cm. No discrete masses are identified. The specimen is submitted entirely. in three cassettes. R: The specimen is received in formalin and labeled \"Left pre sciatic lymph. nodes\" It consists of multiple fragments of soft tan-yellow fibroadipose tissue. measuring in aggregate 2.5 x 1.5 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 0.4 cm in greatest dimension. The specimen is submitted entirely. in one cassette. S: The specimen is received in formalin and labeled \"Right proximal ureter\". It. consists of a segment of ureter with surrounding adipose tissue measuring overall. 1.5 x 1 x 0.4 cm. The ureter measures 0.8 cm in length by 0.2 cm in average. diameter. Two metallic clips are present equidistant from both ends. The specimen. is bisected and submitted entirely in one cassette. T: The specimen is received in formalin and labeled \"Left proximal ureter\". It. consists of a segment of ureter with attached adipose tissue measuring overall 1.5. x. 1 x 0.6 cm. The ureter measures 1 cm in length by 0.2 cm in average diameter. Two metallic clips are present along one end of the ureter. The end opposite the. ureter is inked black and the specimen is trisected and submitted entirely in one. cassette. SECTIONS. AFS: frozen section, right distal ureter. BFS: frozen section, left distal ureter. CFS: frozen section, para-aortic proximal limits lymph nodes. DFS : frozen section, apical ureteral margin. E1-3. bladder and prostate; right anterior and lateral wall of bladder. E4-6: left anterior and lateral wall of bladder. E7 : dome. E8 : posterior wall of bladder. E9 : right ureterovesical junction. E10 : left ureterovesical junction. E11 : trigone. E12 : urethral junction. E13 : right perivesical fat for possible lymph nodes. E14 : left perivesical fat for possible lymph nodes. E15 : prostate, right apex anterior. E16 : prostate, right apex posterior. E17 : prostate, left apex anterior and posterior. E18 : prostate, right mid anterior. SURGICAL PATHOLOCYREROR. E19 : prostate, right mid posterior. E20 : prostate, left mid anterior. E21 : prostate, left mid posterior. E22 : prostate, right base anterior. E23 : prostate, right base posterior. E24 : prostate, left base anterior. E25 : prostate, left base posterior. E26 : right seminal vesicle junction with prostate. E2 : left seminal vesicle junction with prostate. F1 2 : right paracaval lymph nodes; largest lymph node, bisected. F3. one lymph node, bisected. G: left para-aortic lymph nodes - all embedded. H1-4: right common iliac lymph nodes; one large lymph node quadrisected. H5: one lymph node, bisected. H6: remaining tissue. I1: left common iliac lymph nodes; multiple lymph nodes. I2,3: remaining tissue. right lymph nodes of Cloquet; one lymph node, bisected. K1,2. right external iliac lymph nodes; largest lymph node, bisected. K3. one lymph node, bisected. K4. one lymph node, bisected. K5,. remaining tissue. L1-4: right obturator/hypogastric lymph nodes; one large lymph node. quadrisected. L5: one lymph node, bisected. L6: one lymph node, bisected. L7: : three lymph nodes. L8: remaining tissue. M1 : left external iliac lymph nodes; largest lymph node, bisected. M2 : one lymph node, bisected. M3 : one lymph node, bisected. M4: multiple lymph nodes. M5-7: remaining tissue. N: left lymph node of Cloquet; one lymph node, bisected. 01-4: left obturator/hypogastric lymph node; one large lymph node. quadrisected. 05: one lymph node, bisected. 06. remaining tissue. P: right presciatic lymph nodes - all embedded. Q1-3: presacral lymph nodes - all embedded. R: left presciatic lymph nodes - all embedded. S: right proximal ureter - all embedded. left proximal ureter - all embedded. INTRAOPERATIVE FROZEN CONSULTATION: AFS Right distal ureter: no high grade atypia or tumor identified. BFS: Left distal ureter: - no high grade atypia or tumor identified. CFS: Para-aortic proximal limits lymph nodes: - benign. DFS: Apical ureteral margin: no high grade atypia or tumor identified. MICROSCOPIC EXAMINATION: A-C: See final microscopic-diagnoses. D: Permanent sections of the apical urethral margin show single and small clusters. of malignant cells in the periurethral soft tissue, particularly around and within. muscle bundles. A review of the original frozen sections shows rare atypical. cells, that when viewed in context with the main tumor in the bladder and the. permanent sections of the urethral margin are interpreted as representing. carcinoma. The urethral mucosa itself and the immediate underlying support tissue. shows no evidence of urothelial dysplasia or malignancy. E: Sections of the bladder show an invasive poorly differentiated urothelial. carcinoma composed of cells with enlarged hyperchromatic nuclei with coarse. chromatin and prominent central macronucleoli (E1-6) Some of the tumor cells. display signet ring cell features. The tumor invades through the muscularia. propria into the perivesical fat and involves the entire anterior bladder wall as. well as the right and left lateral bladder wall regions. Urothelial carcinoma in. situ (flat lesion) is identified in association with the invasive carcinoma (E4,5). as well as in the trigone region where it is represented by pagetoid spread. Other. random sections of bladder mucosa exhibit foci of moderate urothelial dysplasia and. areas of reactive atypia. The inked bladder resection margins are free of. malignancy. Sections of the prostate show extensive urothelial carcinoma involving. periprostatic soft tissue (E17-23,25) with invasion of prostatic stroma from \"the. outside in\" (E18-21) Lymphovascular invasion is seen (E21,25). Tumor extends to. the right posterior inked margin of the prostate (E19,23) . Tumor involves tissue. around the seminal vesicles without involving the seminal vesicles themselves. (E26,27) The uninvolved prostate shows cystic atrophy and rare foci of high grade. prostatic intraepithelial neoplasia (PIN II) No prostatic adenocarcinoma is seen. F-T: See final microscopic-diagnosis.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Ureter. Histology: Urothelial carcinoma. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Urothelial carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Prostate. Histology: Urothelial carcinoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"STAD\",\n    \"reasoning\": \"Initial code: STAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA STAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"COAD\",\n    \"reasoning\": \"Initial code: COAD. Site: Colon. Histology: Adenocarcinoma. This maps to TCGA COAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LGG\",\n    \"reasoning\": \"Initial code: LGG. Site: Brain. Histology: Glioblastoma. This maps to TCGA LGG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"GBM\",\n    \"reasoning\": \"Initial code: GBM. Site: Brain. Histology: Glioblastoma",
      "predicted": "UROS",
      "ground_truth": "BLCA",
      "correct": false,
      "reasoning": "Initial code: UROS. Site: Ureter. Histology: Urothelial carcinoma. This maps to TCGA UROS.",
      "idx": 51,
      "timestamp": "2026-01-24T13:29:56.318974"
    },
    {
      "sample_idx": 563,
      "input": "Clinical History/Diagnosis: Left Renal Tumor. Source of Specimen(s): 1: left Kidney resection with Adrenal gland. 2: left paraaortic lymph nodes. Gross Description: Received in two parts. Source of Tissue: 1. Labeled # 1, \"left kidney with mass, portion of. adrenal and hilar lymph node\". Frozen Section Diagnosis: 1FS- RENAL CELL CARCINOMA. Gross Description: Received fresh in a container labeled left kidney with mass, portion. of adrenal and hilar lymph. node\". It consists of a 720 gram left rad...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nClinical History/Diagnosis: Left Renal Tumor. Source of Specimen(s): 1: left Kidney resection with Adrenal gland. 2: left paraaortic lymph nodes. Gross Description: Received in two parts. Source of Tissue: 1. Labeled # 1, \"left kidney with mass, portion of. adrenal and hilar lymph node\". Frozen Section Diagnosis: 1FS- RENAL CELL CARCINOMA. Gross Description: Received fresh in a container labeled left kidney with mass, portion. of adrenal and hilar lymph. node\". It consists of a 720 gram left radical nephrectomy consisting of. left kidney measuring 15.0 X 8.0 x 7.0 cm with attached fat ranging from. 0.1 up to 3.5 cm from point of attachment. At the hilum the segment of. ureter measures 9.0 X 0.5 cm with a pin point Jumen and no suspicious. areas. The vessels are also normal. At the superior aspect of the hilum. there is a portion of adrenal gland measuring 2.8 X 1.5 X 0.4 cm. The. adrenal gland is normal. The kidney is bivalved disclosing a large soft. mass centrally in the kidney that measures 9.0 X 6.0 X 7.0 cm. The kidney. is orangish yellow to red in color and centrally within the mass is a. large cyst containing gelatinous, necrotic material. The tumor comprises. approximately 60% of the nephrectomy and markedly distorts the calyceal. system. The mass is pushing on the capsule in multiple areas however no. gross invasion is found. Multiple representative sections of the tumor in. relationship to the capsule and overlying fat will be submitted for. histological impression. Elsewhere, adjacent to the tumor the kidney is. normal appearing with the usual cortical-medullary junctions. Dissection. through the fat and the hilum discloses moist glistening adipose tissue. and no nodal tissue is found. Fresh tissue is procured and sent for. Cytogenetics and Gross Photos are taken. Designation of Sections: 1A - vascular and ureter margins, 1B- adrenal. gland, 1C- tumor pushing on hilum, 1D-1E- tumor pushing on pelvis, 1F-1H-. tumor in relationship to capsule and fat, 1I-1J- tumor in relationship to. adjacent normal parenchyma, 1K-1L- perinephric fat. Source of Tissue: 2. Labeled # 2, \"left para aortic lymph nodes\". Gross Description: Received fresh in a container labeled 'left para aortic lymph nodes\". It consists of multiple. fragments of fibroadipose tissue measuring 4.0 X 4.0 X 1.5 cm. Dissection. through the tissue discloses a few normal appearing and fatty nodes. ranging from 0.1 up to 2.5 cm. Designation of Sections: 2A-2D- - multiple single lymph nodes and fat, 2E-. single bisected lymph node, 2F- single bisected node. Final Diagnosis: 1. Kidney and adrenal, left, radical nephrectomy and partial. adrenalectomy: - Renal cell carcinoma, convential type, Fuhrman grado III (9 cm). - The tumor appears confined to the kidney. - Adrenal gland, No tumor seen. Note: The tumor shows admixed areas of low grade clear cell carcinoma, and. higher grade tumor with abundant granular cytoplasm (both can be seen in. convential type renal cell carcinoma). 2. Left para aortic lymph nodes, excision: - No tumor seen in sixteen lymph nodes (0/16). - pT2NOMx. FCGTL: Chromo15, Chrom45, Interp. Procedures/Addenda. FC Cytogenetics Solid Tumor. Interpretation. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Clear Cell Renal Cell Carcinoma. KARYOTYPE: Abnormal mosaic male karyotype: 38. 44,XY,del(3)(p13),+mar[cp4)/46,XY[13). RESULTS: The renal tumor was harvested after six and eleven days in. culture. Seventeen metaphases were found in a scan of twelve slides. The. chromosomes from these metaphases were counted and analyzed, and four of. these metaphases were karyotyped by G-banding. Four cells had between 38. and 44 chromosomes and contained a deletion in the p arm of chromosome 3. as well as a marker chromosome. Thirteen cells had a modal chromosome. number of 46 and appeared to have a normal karyotype. The deletion in 3p. is characteristic of clear cell renal cell carcinoma.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA",
      "predicted": "KIRC",
      "ground_truth": "KIRC",
      "correct": true,
      "reasoning": "Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.",
      "idx": 563,
      "timestamp": "2026-01-24T13:29:56.318987"
    },
    {
      "sample_idx": 501,
      "input": "MEDICAL RECORD. Surgical. Pathology Report Carenoma renal all deronophable. PROCEDURE DATE: SEX: M. SIGN-OUT DATE: ATTENDING: REQUESTING: CONTACT NO: ROOM: COPIES TO: DIAGNOSIS: Kidney, right, radical nephrectomy: Renal cell carcinoma, chromophobe cell type, Fuhrman nuclear. grade II; no capsular invasion seen; vascular, urteral and inked surgical margins of resection are free of tumor; no. tumor seen in three lymph nodes (0/3); see note. NOTE: Kidney Nephrectomy Summary Table Macroscopic. Speci...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMEDICAL RECORD. Surgical. Pathology Report Carenoma renal all deronophable. PROCEDURE DATE: SEX: M. SIGN-OUT DATE: ATTENDING: REQUESTING: CONTACT NO: ROOM: COPIES TO: DIAGNOSIS: Kidney, right, radical nephrectomy: Renal cell carcinoma, chromophobe cell type, Fuhrman nuclear. grade II; no capsular invasion seen; vascular, urteral and inked surgical margins of resection are free of tumor; no. tumor seen in three lymph nodes (0/3); see note. NOTE: Kidney Nephrectomy Summary Table Macroscopic. Specimen Type: Radical nephrectomy. Laterality: Right. Tumor Size: 5x5x4cm. Focality: Unifocal. Macro Extent of Tumor: Confined to kidney, upper pole, laterally. Microscopic. Histologic Type: Renal cell carcinoma, chromophobe cell type. Histologic Grade: Fuhrman nuclear grade II. Extent of Invasion. Primary Tumor(pT): pT1b. Regional Lymph Nodes(pN): pNO. Distant Metastisis(pM). pMx. Margins: Vascular, ureteric and surgical margins of resection are free of tumor. CLINICAL INFORMATION: Brief Clinical History: yo male with 4. .5cm right renal mass,. incidental diagnosis, sporadic tumor Requestor Name. File in Section 3: Tissue Examination. MEDICAL RECORD. Requestor Phone/Pager: Allocate Order to Protocol: PROCEDURE: Operative Findings: n/a Post-Operative Diagnosis: same Pre-Operative. Diagnosis: right renal mass. SPECIMENS SUBMITTED: 1. KIDNEY, RIGHT. GROSS DESCRIPTION: Received fresh from the OR labeled with the patient's name, medical record number,. and \"right kidney and adrenal\" is a specimen that consists of a radical nephrectomy specimen with attached. adrenal gland entirely measuring, in total, 15 x 9 x 6 cm. The specimen is inked in black and bisected revealing. a. 5 x 5 x 4 cm tumor mass with a brown/yellow cut surface. 40% of the tumor mass is procured for. along with. representative sections of normal adrenal and kidney. The procurement is performed by. on. At. the specimen received matches the above description and weighs 240 grams. The kidney. is further serially sectioned. The tumor is towards the upper half of the kidney laterally towards the upper lateral. pole. The renal capsule appears to be focally adherent over the tumor. The adrenal is well away from the tumor. and the fat around the adrenal is not apposed to the tumor. Sections are submitted as follows: : Vascular and ureteral cut margins. and C: Sections from areas suspicious for capsule adherence including up to inked surgical margin. :: Representative section from center of tumor. Section of tumor including renal pelvic fat. Tumor with adjacent apparent uninvolved kidney. Tumor including kidney and suprarenal fat. Adrenal with surrounding fat. Cection from grossly normal kidney. J and K: Probable lymph node candidates from the renal hilum. Gross dictated by. No consultants. MEDICAL RECORD. Nam. Date OT report:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to",
      "predicted": "KIRC",
      "ground_truth": "KICH",
      "correct": false,
      "reasoning": "Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.",
      "idx": 501,
      "timestamp": "2026-01-24T13:29:56.319000"
    },
    {
      "sample_idx": 457,
      "input": "DIAGNOSIS. (A) TEETH: (B) LEFT NECK DISSECTION, LEVEL I \"A\": Teeth identified, gross identification only. One lymph node, no tumor present (0/1). (C) LEFT PARTIAL GLOSSECTOMY:: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 7.2 cm in largest dimension. Invasion: Present, depth 0.6 cm. Tumor Border: infiltrative. Perineural Invasion: Absent. Vascular Invasion: Absent. Lymphocyte Infiltration: Absent. Mucosal Margin: (en-face) Negative for invasive carc...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nDIAGNOSIS. (A) TEETH: (B) LEFT NECK DISSECTION, LEVEL I \"A\": Teeth identified, gross identification only. One lymph node, no tumor present (0/1). (C) LEFT PARTIAL GLOSSECTOMY:: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 7.2 cm in largest dimension. Invasion: Present, depth 0.6 cm. Tumor Border: infiltrative. Perineural Invasion: Absent. Vascular Invasion: Absent. Lymphocyte Infiltration: Absent. Mucosal Margin: (en-face) Negative for invasive carcinoma. Deep Margin: (radial) Negative for invasive carcinoma. Dysplasia at Margin: Absent. (D) LEFT NECK DISSECTION, LEVEL I: Seven lymph nodes, no tumor present (0/7). Salivary tissue, no tumor present. (E) LEFT NECK DISSECTION, LEVEL II: Twenty-two lymph nodes, no tumor present (0/22). (F) LEFT NECK DISSECTION, LEVEL III: Ten lymph nodes, no tumor present (0/10). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TEETH - Multiple fragments of white-tan teeth. The specimen is for gross examination only. (B) LEFT NECK DISSECTION, LEVEL I \"A\" - A 0.9 X 0.5 X 0.4 cm lymph node. The specimen is submitted entirely in cassette. B. (C) LEFT PARTIAL GLOSSECTOMY - Specimen consists of a portion of tongue (7.5 X 6.7 X 4.5 cm) with a centrally placed. exophytic verrucous tumor (7.2 X 6.3 X 2.5 cm). The closest mucosal margin is posteriorly towards the base of tongue (0.4 cm). The tumor appears to possibly superficially invade the muscle of the tongue, but the deep margin is widely free of tumor. The. lingual nerve is identified by the surgeon and is grossly unremarkable. INK CODE: Black - deep margin. SECTION CODE: C1, superior/anterior mucosal margin for frozen section; C2, superior mid, mucosal margin for. frozen. section; C3, superior posterior mucosal margin for frozen section; C4, base of tongue, medial mucosal margin for frozen. section; C5, base of tongue, lateral mucosal margin for frozen section; C6, lateral posterior mucosal margin for frozen section;. C7, lateral mid mucosal margin for frozen section; C8, lateral anterior mucosal margin for frozen section; C9, anterior mucosal. margin. for frozen section; C10, representative sections of the lingual for frozen section; C11, representative section of tumor. with closest deep margin for frozen section; C12-C20. representative sections of tumor with underlying tongue, submitted. anterior to posterior (deep margin in C13-C15). FS/DX: NO TUMOR PRESENT AT MARGINS. (D) LEFT NECK DISSECTION LEVEL I - An unoriented, tan-pink fragment of fibrofatty tissue (7.0 X 6.5 X 2.5 cm). Dissection. reveals a tan, grossly unremarkable submandibular gland (6.0 X 5.0 X 2.5 cm). Nine lymph nodes are identified, ranging from. (0.2 X 0.1 X 0.1 cm to 2.0 X 1.5 X 1.0 cm). SECTION CODE: D1, five lymph nodes: D2 three lymph nodes; D3, D4, one lymph node, serially sectioned; D5,. representative section of submandibular gland. (E) LEFT NECK DISSECTION LEVEL II - An unoriented, tan-pink fragment of fibrofatty tissue (9.0 X 5.5 X 2.0 cm). Dissection. reveals 24 lymph nodes ranging from (0.1 X 0.1 X 0.1 cm to 3.0 X 1.5 X 1.0 cm). SECTION CODE: E1, six lymph nodes; E2, five lymph nodes; E3, three lymph nodes; E4, three lymph nodes; E5, two. lymph. nodes; E6, one lymph node, trisected; E7, one lymph node, serially sectioned; E8, one lymph node, trisected; E9, one. lymph node, trisected; E10, E11, one lymph node, serially sectioned. (F) LEFT NECK DISSECTION LEVEL III - An unoriented, tan-pink fragment or fibrofatty tissue (7.0 X 4.5 X 1.5 cm). Dissection. reveals 10 lymph nodes ranging from (0.3 X 0.2 X 0.2 cm to 2.5 X 2.0 X 1.5 cm). SECTION CODE: F1, four lymph nodes; F2, three lymph nodes; F3, two lymph nodes; F4, one lymph node, serially. sectioned. CLINICAL HISTORY. None given. SNOMED CODES. T-53000, M-80703. \"Some tests reported here may have been developed and performance characteristics determined b. Pathology and Laboratory Medicine. These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration.\". Released by:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"",
      "predicted": "SCC",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.",
      "idx": 457,
      "timestamp": "2026-01-24T13:29:56.319011"
    },
    {
      "sample_idx": 285,
      "input": "SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer cecum. GROSS DESCRIPTION. Received fresh labeled \"right colon\" is a previously. unopened 30 cm. segment of proximal right colon with. attached 19 cm. of distal ileum surfaced by smooth scabrous tan pink. serosa with a copious amount of attached mesocolon and mesentery. An unremarkable 3.9 cm. appendix averaging 0.5 cm. in diameter is. present. The proximal and distal margins measures 4.5 and 8.0 cm. in circumference respectively. On...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer cecum. GROSS DESCRIPTION. Received fresh labeled \"right colon\" is a previously. unopened 30 cm. segment of proximal right colon with. attached 19 cm. of distal ileum surfaced by smooth scabrous tan pink. serosa with a copious amount of attached mesocolon and mesentery. An unremarkable 3.9 cm. appendix averaging 0.5 cm. in diameter is. present. The proximal and distal margins measures 4.5 and 8.0 cm. in circumference respectively. On opening there is a well. circumscribed, 5.5 X 4.9 cm. rubbery white pink-red tumor. immediately distal to the ileocecal valve. A portion of tumor and a. portion of normal mucosa are submitted for tissue procurement as. requested. On sectioning, the tumor has a maximal thickness of 1.0. cm. and appears to extend into the muscularis and extend to within. 1.2 cm. of the inked serosal surface. The ileal mucosa is. unremarkable, tan-pink with regular folds and the walls average 0.5. cm. in thickness. A soft tan-pink colonic polyp is present. measuring 0.2 cm. in greatest dimension, 11 cm. distal to the main. tumor (see block 8) No additional mass lesion or abnormality is. identified. Multiple soft to slightly rubbery pale tan tissues in. keeping with lymph nodes measuring up to 1.3 cm. in greatest. dimension are recovered from the attached mesocolon and mesentery. entative sections are submitted in 17 blocks as labeled. BLOCK SUMMARY: 1 - Proximal and distal margins; 2 - tumor to inked. free radial serosal surface; 3, 4 - central tumor; 5 - tumor to ICV;. 6 - tumor to distal mucosa; 7 - random ileum; 8 - colon with small. polyp; 9 - random colon; 10 - appendix; 11-13 - ole lymph nodes;. 14-17 - one bisected lymph node per cassette. MICROSCOPIC DESCRIPTION. This right hemicolectomy specimen contains a moderately. differentiated adenocarcinoma of the cecum, involving the cecal side. of the ileocecal valve. Please see the template below: Histologic type: Adenocarcinoma. Histologic grade Moderately differentiated. Primary tumor (pT) : The tumor invades nearly the full thickness of. the muscularis propria, (pT2). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: The tumor measures 1.2 cm. from the inked serosal surface and 19 cm from the proximal margin. Vascular invasion: Negative. Regional lymph nodes (pN) : Twenty-four lymph nodes are found, all. Of which are negative for metastatic disease, 0/24 (pNO). Non-lymph node pericolonic tumor: Negative. Distant metastasis (pM) : Cannot be assessed. Other findings: A 2 mm adenomatous polyp is noted within the colon. Ileum and appendix, no significant pathology. DIAGNOSIS. Right colon, right hemicolectomy - Moderately-differentiated. adenocarcinoma. of the cecum extending into but not through the muscularis. propria. No. lymphatic invasion found and all twenty-four lymph nodes are. negative for. metastatic disease. All margins are negative for tumor. An. incidental. 2 mm adenomatous polyp is noted within the right colon. Terminal ileum and appendix, no significant pathology. End Of Report ---.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "COAD",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 285,
      "timestamp": "2026-01-24T13:29:56.319023"
    },
    {
      "sample_idx": 209,
      "input": "P.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nP.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF THE TOTAL TUMOR VOLUME AND IS. PRESENT ADMIXED WITH THE INVASIVE COMPONENT. F. THE DUCTAL CARCINOMA IN SITU (DCIS) IS PRESENT IN 12/22 SLIDES. G. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. H. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. DUCTAL CARCINOMA IN SITU (DCIS) IS 4.0 MM. FROM THE NEAREST ANTERIOR MARGIN, THE INVASIVE CARCINOMA IS GREATER THAN 1.0 CM FROM ALL. MARGINS. I. THE NIPPLE IS INVOLVED BY DUCTAL CARCINOMA IN SITU. J. SKIN IS NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST: INTRADUCTAL PAPILLOMA AND FIBROCYSTIC CHANGES WITH. FIBROADENOMATOID NODULES,. L. BIOPSY SITE CHANGES WITH FAT NECROSIS. M. METASTATIC CARCINOMA INVOLVING FOUR OF TWENTY-SIX LYMPH NODES (4/26). N. THE LARGEST METASTATIC FOCUS MEASURES 2.0 CM. O. EXTRACAPSULAR EXTENSION IS IDENTIFIED AND MEASURES 1 MM. P. THE INVASIVE TUMOR CELLS TESTED POSITIVE FOR ESTROGEN AND WEAKLY POSITIVE FOR. PROGESTERONE RECEPTORS AND NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. LASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2 5 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitolic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION;. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. Comedo. DCIS admixed with invasive carc\u00ednoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupled by in situ component 50 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: Distance of in silu disease to closest margin: 40 mm. LYMPH NODES POSITIVE: 4. LYMPH NODES EXAMINED: 26. METHOD(S) OF LYMPH NODE EXAMINATION: H/E levels. SIZE OF NODAL METASTASES: Diameter of largest lymph nodo metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Papillonia, FCD, Other: Fibroadenomatoid nodules. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGEST\u00c9RONE RECEPTORS: positive. HER2/NEU:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json",
      "predicted": "BRCA",
      "ground_truth": "BRCA",
      "correct": true,
      "reasoning": "Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.",
      "idx": 209,
      "timestamp": "2026-01-24T13:29:56.319035"
    },
    {
      "sample_idx": 1385,
      "input": "SLIDE DISPOSITION: DIAGNOSIS: A. Uterus, hysterectomy: High grade serous carcinoma is. identified. forming a mass (7.0 x 4.1 x 0.4 cm) circumferentially. involving the. endometrial cavity. The tumor invades 0. 4 cm into the. myometrium. (total myometrial thickness, 1.6 cm). The tumor does not. involve. the endocervix. Lymphovascular space invasion is. identified. The. margins are negative for tumor. B. Lymph nodes, right and left para-aortic,. lymphadenectomy : Multiple (6 of 9) lymph nodes posi...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSLIDE DISPOSITION: DIAGNOSIS: A. Uterus, hysterectomy: High grade serous carcinoma is. identified. forming a mass (7.0 x 4.1 x 0.4 cm) circumferentially. involving the. endometrial cavity. The tumor invades 0. 4 cm into the. myometrium. (total myometrial thickness, 1.6 cm). The tumor does not. involve. the endocervix. Lymphovascular space invasion is. identified. The. margins are negative for tumor. B. Lymph nodes, right and left para-aortic,. lymphadenectomy : Multiple (6 of 9) lymph nodes positive for metastatic. carcinoma,. consistent with endometrial primary. C. Ovary and fallopian tube, right, salpingo-. oophorectomy High. grade serous carcinoma forming an intraluminal cystic mass. involving. the right fallopian tube. The right ovary is atrophic. D. Ovary and fallopian tube, left, salpingo-oophorectomy: High. grade serous carcinoma involving the adnexal soft tissue. and. atrophic ovary. The left fallopian tube is unremarkable. E. Lymph nodes, right and left pelvic, lymphadenectomy: Multiple. (2 of 21) lymph nodes are positive for metastatic. carcinoma,. consistent with endometrial primary. F. Omentum, omentectomy: Negative for tumor. With available surgical materials, [AJCC (7th edition). pT3aN2]. PRELIMINARY FROZEN SECTION CONSULTATION. A. Uterus, hysterectomy : Serous carcinoma. The margins. are. negative for tumor. C. Ovary and fallopian tube, right, salpingo-. oophorectomy : Carcinoma involving the right fallopian tube. The right. ovary is. atrophic. D. Ovary and fallopian tube, left, salpingo-oophorectomy: Carcinoma involving the adnexal soft tissue and ovary. The left. fallopian tube is unremarkable. F. Omentum, omentectomy: Negative for tumor. HOLD to process lymph nodes on permanent sections. Frozen section histologic interpretation performed by: GROSS DESCRIPTION: A. Received fresh labeled \"uterus\" is a 123.0 gram uterus. with an. unremarkable cervix. The uterine serosa is smooth There. is a 7.0 x. 4.1 X 1.1 cm mass involving the entire endometrial cavity. and lower. uterine segment which grossly appears to invade 0.2 cm. into the 1.6. cm thick myometrium. Representative sections are. submitted. B. Received fresh labeled \"right and left para-aortic. nodes\" is a. 5. 4 X 4.5 x 1.9 cm aggregate of adipose tissue and lymph. nodes. All. lymph nodes submitted. C. Received fresh labeled \"right tube and ovary\" is a 2.0. x 1.4 X. 0.6 cm ovary with an 8.0 x 0.6 cm attached fallopian tube. with a 1.0. x 0.8 cm paratubal cyst. The ovary has a smooth outer. surface and a. solid cut surface. Representative sections submitted. D. Received fresh labeled \"left tube and ovary\" is a 2.5. x 1.2 x. 0.7 cm ovary with a 7.0 x 0.4 cm attached fallopian tube. The ovary. has a smooth outer surface and a solid cut surface. Representative. sections submitted. E. Received fresh labeled \"right and left pelvic lymph. nodes\" is a. 9.8 X 7. 4 X 1.2 cm aggregate of adipose tissue and lymph. nodes. All. lymph nodes submitted. F. Received fresh labeled \"dependent omentum\" is a 17.2 x. 13.0 x. 1.5 cm portion of omentum. No masses are identified. grossly. Lymph. nodes are not identified. Representative sections. submitted. BLOCK SUMMARY: Part A: Uterus. 1 Endometrial tumor. 2 Cervix. 3 Endocervix. 4 Endometrial tumor-2. 5 Endometrial tumor-3. 6 Endometrial tumor-4. 7 Endometrial tumor-5. Part B: Right and left para aortic lymph nodes. 1 Rt/Lt paraaortic LN 2 (B1). 2 Rt/Lt paraaortic LN 1 (B2). 3 Rt/Lt paraaortic LN 2 (B3). 4 Rt/Lt paraaortic fat- 1. 5 Rt/Lt paraaortic fat-2. 6 Rt/Lt paraaortic LN 1 (B4). Part C: Right tube and ovary. 1 Right fallopian tube. 2 Right ovary. Part D: Left tube and ovary. 1 Left fallopian tube. 2 Left ovary. 3 Left adnexal tissue. Part E: Right & left pelvic Lymph Nodes. 1 Pelvic LNs-! 5 (E1). 2 Pelvic LNs- - 2 (E2). 3 Pelvic LNs- - 5 (E3). 4 Pelvic LNs- - 2 (E4). 5 Pelvic LNs- - 3 (E5). 6 Pelvic LNs- - 2 (E6). 7 Pelvic LN-1 (E7). 8 Pelvic LN- 1 (E8). 9 Pelvic LNs- - 2 (E9). 10 Pelvic LNs - 4 (E10). 11 Pelvic LN-1 (E11). Part F: Dependent Omentum. 1 Dependent omentum.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology",
      "predicted": "UCEC",
      "ground_truth": "UCEC",
      "correct": true,
      "reasoning": "Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.",
      "idx": 1385,
      "timestamp": "2026-01-24T13:29:56.319047"
    },
    {
      "sample_idx": 1116,
      "input": "Clinical Diagnosis & History: year old with large right retroperitoneal sarcoma encasing vena cava. biopsy (+) leiomyosarcoma. Specimens Submitted: 1: SP: Abdominal leiomyosarcoma. DIAGNOSIS: 1. SOFT TISSUE, RETROPERITONEAL; RESECTION: -HIGH GRADE LEIOMYOSARCOMA INVLOVING WALL OF VENA CAVA. -TUMOR DIMENSIONS: 14 x 13 x 10 CM. FOCAL NECROSIS (LESS THAN 10%) IS PRESENT. -SURGICAL MARGINS (SOFT TISSUE AND VENA CAVA) ARE FREE OF TUMOR. FOCALLY TE TUMOR IS WITHIN 0.2 CM OF SOFT TISSUE MARGIN, HOWEVER...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nClinical Diagnosis & History: year old with large right retroperitoneal sarcoma encasing vena cava. biopsy (+) leiomyosarcoma. Specimens Submitted: 1: SP: Abdominal leiomyosarcoma. DIAGNOSIS: 1. SOFT TISSUE, RETROPERITONEAL; RESECTION: -HIGH GRADE LEIOMYOSARCOMA INVLOVING WALL OF VENA CAVA. -TUMOR DIMENSIONS: 14 x 13 x 10 CM. FOCAL NECROSIS (LESS THAN 10%) IS PRESENT. -SURGICAL MARGINS (SOFT TISSUE AND VENA CAVA) ARE FREE OF TUMOR. FOCALLY TE TUMOR IS WITHIN 0.2 CM OF SOFT TISSUE MARGIN, HOWEVER IS WELL. LIMITED BY FIBROUS MEMBRANOUS TISSUE AND ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh labeled \"abdominal leiomyosarcoma\" and. consists of an irregular soft tissue mass with dimensions of 16 x 14 x 11. cm. The specimen is covered by ragged fat, focal skeletal muscle, patches of. peritoneum, and a focal thin fibrous membrane. There is an adherent 9 cm. segment of vein with a diameter of 1 cm that is stapled at both ends. Sectioning reveals a well-circumscribed tumor with dimensions of 14 x 13. x. 10 cm. The tumor has a tan, rubbery, whorled cut surface with central. hemorrhage and white fibrous areas. No gross necrosis is identified. The. tumor appears to invade the surrounding fat with a pushing border. The tumor. is adherent to the large vessel but does not appear to extend to the entire. wall. The endothelial surface is tan and smooth. The tumor abuts the thin. SURGICAL. fibrous capsule. Gross photographs are taken, tissue is submitted for TPS,. and representative sections are submitted. Summary of sections: TP-tumor to peritoneum. TF-tumor to fibrous membrane. TM-tumor to muscle. TV-tumor to vessel. VM-vessel margins. T-tumor representative sections. Summary of Sections: Part 1: SP: Abdominal leiomyosarcoma. Block. Sect. Site. PCs. 10. T. 10. 1. TF. 1. 1. TM. 1. 1. TP. 1. 2. TV. 2. 1. VM. 2.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PR",
      "predicted": "PRAD",
      "ground_truth": "SARC",
      "correct": false,
      "reasoning": "Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.",
      "idx": 1116,
      "timestamp": "2026-01-24T13:29:56.319058"
    },
    {
      "sample_idx": 178,
      "input": "Final Diagnosis. A. Breast, left, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III). [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9] is identified forming a mass (4.8 x. 2.7 x 1.9 cm) located in the lower outer quadrant of the breast. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Lobular. carcinoma in situ is also present. All surgical resection margins, including the deep margin, are. n...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFinal Diagnosis. A. Breast, left, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III). [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9] is identified forming a mass (4.8 x. 2.7 x 1.9 cm) located in the lower outer quadrant of the breast. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Lobular. carcinoma in situ is also present. All surgical resection margins, including the deep margin, are. negative for tumor (minimum tumor free margin, 0.3 cm, deep margin and 0.5 cm, superficial. margin). With available surgical material, the AJCC staging is pT2NXMX (see comment). B. Breast, right, simple mastectomy: Benign nonproliferative breast parenchyma. C. Lymph nodes, left axillary, lymphadenectomy: Multiple (14) lymph nodes are negative for. tumor. D. Lymph nodes, left lowest axillary, lymphadenectomy: Fibroadipose tissue, negative for. tumor. No lymphoid tissue identified.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "BRCA",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 178,
      "timestamp": "2026-01-24T13:29:56.319069"
    },
    {
      "sample_idx": 1209,
      "input": "Case ID. 2. Gross. Microscopic Description. Diagnosis Details. Description. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Subtotal resection of stomach. Tumor site: Fundus. Tumor size: 6x5x4cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/12 positive for metastasis (Regional. 0/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not speci...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nCase ID. 2. Gross. Microscopic Description. Diagnosis Details. Description. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Subtotal resection of stomach. Tumor site: Fundus. Tumor size: 6x5x4cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/12 positive for metastasis (Regional. 0/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json",
      "predicted": "LUAD",
      "ground_truth": "STAD",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.",
      "idx": 1209,
      "timestamp": "2026-01-24T13:29:56.319086"
    },
    {
      "sample_idx": 864,
      "input": "Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.9000000000000004. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2b. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. A...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.9000000000000004. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2b. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA",
      "predicted": "LUAD",
      "ground_truth": "LUSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.",
      "idx": 864,
      "timestamp": "2026-01-24T13:29:56.319097"
    },
    {
      "sample_idx": 65,
      "input": "BIOPSY OR SURGICAL SPECIMEN (Order. Patient Information. Provider Status. Component. Lab. FINAL PATHOLOGICAL DIAGNOSIS. A. Left distal ureter, radical cystoprostatectomy: Unremarkable urothelium; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. B. Right distal ureter, radical cystoprostatectomy: - Unremarkable urothellum; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. C. Bladder and prostate, radical cystoprostat...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nBIOPSY OR SURGICAL SPECIMEN (Order. Patient Information. Provider Status. Component. Lab. FINAL PATHOLOGICAL DIAGNOSIS. A. Left distal ureter, radical cystoprostatectomy: Unremarkable urothelium; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. B. Right distal ureter, radical cystoprostatectomy: - Unremarkable urothellum; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. C. Bladder and prostate, radical cystoprostatectomy: - Invasive urothelial carcinoma with squamous differentiation, high grade. - Tumor invades perivesical tissue macroscopically (pT3b). - All surgical resection margins free of tumor. - Prostate with benign prostatic hyperplasia; no invasive carcinoma identified. - See CAP template below for full report. - See comment. D. Right Iliac lymph nodes, lymph node dissection: - Five benign lymph nodes identified, all negative for metastatic carcinoma. (0/5). E. Right obturator lymph nodes, lymph node dissection: - Three benign lymph nodes identified, all negative for metastatic carcinoma. (0/3). F. Left iliac lymph nodes, lymph node dissection: - Three benign lymph nodes identified, all negative for metastatic carcinoma. (0/3). G. Left obturator lymph nodes, lymph node dissection: - Ten benign lymph nodes identified, all negative for metastatic carcinoma. (0/10). CAP Cancer Template. Specimen: Bladder. Other (specify): Prostate. Procedure: Radical cystoprostatectomy. Tumor Site: Left lateral wall. Anterior wall. Posterior wall. Right ureteral orifice. Tumor Size: Greatest dimension: 4.5 cm. Histologic Type: Urothelial (transitional cell) carcinoma with squamous differentiation. Associated Epithelial Lesions: None identified. Histologic Grade: Urothellal Carcinoma (WHO 2004/ISUP): High-grade. Tumor Configuration: Solid/nodule. Flat. Ulcerated. Microscopic Tumor Extension: Invades perivesical tissue macroscopically (extravesical mass). Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 mm. Specify margin: Posterior soft tissue margin. Lymph-Vascular Invasion: Indeterminate. Pathologic Staging (pTNM): TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT3b: Macroscopically (extravesicular mass). Regional Lymph Nodes (pN): pNO: No lymph node metastasis. Specify: Number examined: 21. Number involved (any size): 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Urothelial dysplasia. Inflammation/regenerative changes. Ancillary Studies: None performed at this time; blocks C13 and C14 will be held for future studies. if necessary. The above pathology diagnosis incorporates data elements as outlined in the CAP. Cancer Protocols and Checklists which are based on the AJCC/UICC TNM, 7th. edition. DIAGNOSIS COMMENT. Selected slides were reviewed at the. on. and the diagnoses represent a consensus. opinion. \"Electronically Signed Out By. CLINICAL HISTORY. Bladder tumor. Radical cystectomy/ prostatectomy with lleal conduit. SPECIMEN(S) RECEIVED. A: Left distal ureter. B: Right distal ureter. C: Bladder and prostate. D: Right iliac lymph nodes. E: Right obturator lymph nodes. F: Left iliac lymph nodes. G: Left obturator lymph nodes. GROSS DESCRIPTION. Specimen A is received fresh for frozen section labeled with the patient's name. and designated \"left distal ureter\". The specimen consists of a segment of. ureter measuring 0.6 cm in diameter x 0.3 cm in length. Section key: A1 specimen is completely submitted for frozen section. Specimen B is received fresh for frozen section labeled with the patient's name. and designated \"right distal ureter\". The specimen consists of a segment of. ureter measuring 0.4 cm in diameter x 0.3 cm in length. Section key: B1 specimen is completely submitted for frozen section. Specimen C. Type of specimen: Urinary bladder, ureter stumps, prostate, seminal vesicles. The patient's name and case number on the specimen container match the. accompanying paperwork and cassettes. Procedure: Radical cystoprostatectomy. Fixative: Received fresh and later placed in formalin. Dimensions: Bladder: Superior to inferior 7.5 cm, right to left 6.0 cm, anterior to. posterior 3.5 cm. Right ureter stump: 1.0 cm in length and 0.5 cm in diameter; left 2.5 cm in. length and 0.5 cm in diameter. Prostate: Apex to base 3,8 cm, anterior to posterior 3.2 cm, right to left 5.0. cm. Description of findings: Tumor: Three distinct separate tumors are identified. The largest tumor. occupies the left lateral wail and extends to include portions of both the. anterior and posterior wall. In some areas, the tumor appears to abut the inked. posterior bladder surface. This tumor measures 4.5 x 3.6 cm. The central. portion of the tumor is rough, hemorrhagic, and somewhat shaggy and has a. somewhat necrotic appearance. The necrosis involves 80% of the surface of the. tumor. There are tan-gray, nodular, viable areas at the peripheral margin of. the tumor. On section, this tumor can be seen to deeply invade the bladder wall. and appears to have extended through the full thickness to involve the adjacent. perivesicular adipose tissue. The second tumor occupies a portion of the. posterior wall and extends laterally to surround the right ureteral orifice. This tumor measures 2.5 x 2.0 cm. The tumor is largely exophytic extending 0.9. cm above the lining of the bladder wall. The third tumor occupies a portion of. the Inferior anterior bladder wall and measures 1.7 x 1.5 cm and rises 0.6 cm. above the fining of the bladder wall. The lumen of the bladder contains a large. volume of form friable blood clot. The clot measures 7.0 x 7.0 x 2.5 cm. Uninvolved mucosa: The involved mucosa has a normal tan-gray appearance with no. additional lesions noted. Sectioning through the prostate reveals a normal. tan-gray, lobulated, spongy cut surface. Prostate, seminal vesicies and vasa deferentia: Ink code: Anterior: blue. Posterior: black. Right side: orange. Left side: blue. Section key: C1 en face urethral resection margins. C2 largest tumor of left lateral wall, anterior surface. C3 C8 largest tumor of left lateral wall and posterior surface. C9, C10 second tumor of right lateral wall. C11, C12 third tumor anterior wall. C13 left ureteral orifice. C14 right ureteral orifice. C15 right lateral wall. C16 section of dome. C17 C19 right prostate submitted distal to proximal. C20 C22 left prostate submitted distal to proximal. C23 right seminal vesicle and vas deferens. C24 left seminal vesicle and vas deferens. Specimen D is received in formalin labeled with the patient's name and. designated \"right illac lymph node\". The specimen consists of an aggregate of. yellow, fatty tissue measuring 5.0 x 4.3 x 2.5 cm. Multiple lymph nodes are. identified ranging in size from 0.5 cm up to 2.1 cm in greatest dimension. Section key: The lymph nodes are entirely submitted as follows: D1, D2 largest lymph node trisected. D3 two lymph nodes, bisected, one marked with ink. D4 two lymph nodes, bisected, one marked with ink. Specimen E is received in formalin labeled with the patient's name and. designated \"right obturator lymph node\". The specimen consists of an aggregate. of yellow, fatty tissue measuring 5.5 x 3.8 x 2.0 cm. Three lymph nodes are. identified ranging from 0.8 cm up to 3.5 cm in greatest dimension. Section key: The lymph nodes are entirely submitted as follows: E1 E3 largest lymph node trisected. E4, E5 one lymph node, bisected. E6 one single lymph node. Specimen F is received in formalin labeled with the patient's name and. designated \"left illac lymph node\". The specimen consists of an aggregate of. yellow, fatty tissue measuring 3.5 x 2.5 x 1.5 cm. Three lymph nodes are. identified ranging in size from 0.5 cm up to 1.5 cm in greatest dimension. Section key: F1 lymph nodes are completely submitted. Specimen G is received in formalin labeled with the patient's name and. designated \"left obturator lymph node\". The specimen consists of an aggregate. of yellow, fatty tissue measuring 4.5 x 4.0 x 2.3 cm. Multiple lymph nodes are. identified ranging from 0.2 cm up to 3.0 cm in greatest dimension. Section key: Lymph nodes are completely submitted as follows: G1, G2 largest lymph node bisected. G3 two lymph nodes, bisected, one marked with blue ink. G4, G5 multiple single lymph nodes. MICROSCOPIC DESCRIPTION. The stain quality is acceptable. A-G. The microscopic findings are reflected in the diagnoses rendered. INTRAOPERATIVE CONSULT DIAGNOSIS. Time in: Time out: AFS1, Left distal ureter: \"Negative for malignancy\". BFS1, Right distal ureter: \"Negative for malignancy\". Conveyed to. on. Interpretation performed at: Anatomic Pathology Report - Scan on. Result History. BIOPSY OR SURGICAL SPECIMEN. Transcription. Type. Author. Document Text. Display only: Transcription (. Date and Time. This order is currently not shared in. BIOPSY OR SURGICAL SPECIMENT. Patient Information. Visit Information. Time. Department. Provider. Urology. Admission Information. Attending Provider. Admitting Provider. Admission Type. Admission Date/Time. Discharge Date. Hospital Service. Auth/Cert Status. Service Area. Admission Status. Unknown Status (No Confirmation. Date and Time. Authorizing. Department. Urology. Code. BIOPSY OR SURGICAL SPECIMEN. Discharge Information. Discharge Provider. Date/Time. Disposition. Destination. (none). (none). (none). (none). Authorizing Provider. Encounter Provider. Anatomic Pathology Report - Scan. Date and Time. Priority and Order Details. Priority. Class. Routine.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Prostate. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TC",
      "predicted": "UROS",
      "ground_truth": "BLCA",
      "correct": false,
      "reasoning": "Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.",
      "idx": 65,
      "timestamp": "2026-01-24T13:29:56.319109"
    },
    {
      "sample_idx": 61,
      "input": "De-Identified Specimen Code. / M. SPECIMEN SUBMITTED: Part A: LEFT DISTAL URETER. Part B: RIGHT DISTAL URETER. Part C: BLADDER/ PROSTATE. Part D: RIGHT PELVIC LYMPH NODES. Part E: LEFT PELVIC LYMPH NODES. Final Diagnosis. 1. Left and right distal ureters, biopsy (A, B) - Negative for neoplasm. 2. Bladder, excision (C) - Invasive poorly differentiated urothelial carcinoma with invasion through. muscular wall and involvement of perivesical adipose tissue. 3. Prostate, excision (C) - Glandular hype...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nDe-Identified Specimen Code. / M. SPECIMEN SUBMITTED: Part A: LEFT DISTAL URETER. Part B: RIGHT DISTAL URETER. Part C: BLADDER/ PROSTATE. Part D: RIGHT PELVIC LYMPH NODES. Part E: LEFT PELVIC LYMPH NODES. Final Diagnosis. 1. Left and right distal ureters, biopsy (A, B) - Negative for neoplasm. 2. Bladder, excision (C) - Invasive poorly differentiated urothelial carcinoma with invasion through. muscular wall and involvement of perivesical adipose tissue. 3. Prostate, excision (C) - Glandular hyperplasia. -Chronic inflammation. 4. Seminal vesicles, right and left, excision (C) - Negative for neoplasm. 5. Right pelvic lymph nodes, excision (D) - Negative for neoplasm, ten lymph nodes. 6. Left pelvic lymph nodes, excision (E) - Negative for neoplasm, ten lymph nodes. Diagnosis Comment: 2. Specimen Type: Radical cystoprostatectomy. Tumor Size, Greatest dimension: 3.0 cm. Histologic Type: Urothelial carcinoma with glandular and squamous differentiation. Urothelial Carcinoma: (WHO/ISUP, 1998) High-grade. Associated Epithelial Lesions: High-grade papillary urothelial carcinoma in previous biopsy specimen. Margins: Margins uninvolved by invasive cancer. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Direct Extension of Invasive Tumor: Perivesical fat. Other Diagnoses: See above. Pathologic Stage: Primary Tumor: (pT). pT3b: Macroscopically invades perivesical fat (extravesical mass). Regional Lymph Nodes: (pN). pNO: No regional lymph node metastasis. Distant Metastasis (pM): pMX: Cannot be assessed. Clinical Diagnosis: BLADDER CA. Gross Description: A. Received fresh at the frozen desk is a specimen labeled \"left distal ureter\" consisting of one piece of. luminal tissue measuring 1 x 1 x 0.5 cm. The specimen is unoriented. The specimen is bisected and. totally submitted for frozen section as A1. B. Received fresh at the frozen desk is a specimen labeled \"right distal ureter\" consisting of one piece. of unoriented luminal tissue measuring 1 x 0.5 x 0.5 cm. The specimen is bisected and totally. submitted for frozen section as B1. C. Received in formalin labeled \"bladder and prostate\" is a specimen consisting of a urinary bladder with. attached prostate and seminal vesicles. The bladder measures 11 x 10 X 4 cm. The exterior surface of. the bladder is covered by fibroadipose tissue and is inked black. After the bladder is opened, a polypoid. mass measuring 0.7 x 0.6 x 0.6 cm is identified in the left posterior inferior wall of the bladder 0.2 cm. from the left ureter. On sectioning, the mass extends through the muscularis into the surrounding. adipose tissue but appears to be 0.4 cm from soft tissue margin (inked black). The tumor portion. involving the bladder wall has the following dimensions: 3 x 1.5 x 1.5 cm. The remaining bladder. mucosa is slightly edematous. A segment of right ureter is 1 cm. It is patent with unremarkable. mucosa. A segment of left ureter is 1 cm. Its mucosa is roughened, but it is patent. The prostate. measures 3.5 cm transversely, 3 cm anteroposteriorly, and 3 cm craniocaudally. The capsular surface. is smooth. The gland is inked blue on the right, and yellow on the left. The gland is sectioned from apex. to base transversely at 3 mm intervals perpendicular to the urethra. The cross sections do not reveal a. mass lesion. Rubbery nodularity is not present. The seminal vesicles are unremarkable. Sections are. submitted as follows: C1 right ureteric margin, C2 left ureteric margin, C3 urethral margin, C4 tumor with. deepest extension, C5-C8 tumor involving bladder wall, C9 left ureter, C10 right ureter, C11 posterior. bladder wall, C12 right bladder wall, C13 left bladder wall, C14 bladder dome, C15 bladder trigone, C16. right apex of the prostate, C17 left apex of the prostate, C18 right mid portion of the prostate at 9 mm,. C19 left mid portion of the prostate at 9 mm, C20 right base of the prostate with right seminal vesicle,. C21 left base of the prostate, C22 left seminal vesicle, C23 anterior bladder wall. D. Received fresh labeled \"right pelvic lymph node\" are multiple irregular segments of fibroadipose. tissue aggregating to 6.0 x 4.0 x 1.0 cm. Palpation reveals 10 tan-pink firm nodules resembling lymph. nodes ranging in size from 0.7 to 5.0 cm in greatest dimension. The nodules are totally submitted in. formalin as follows: D1 two nodules; D2 two nodules; D3 two nodules; D4 two nodules; D5 one nodule;. D6-D9 largest nodule, serially sectioned, totally submitted. E. Received fresh labeled \"left pelvic lymph nodes\" are multiple irregular segments of fibroadipose. tissue aggregating to 6.0 x 5.5 x 1.5 cm. Palpation reveals 17 tan-pink firm nodules resembling lymph. nodes ranging in size from 0.2 to 6.0 cm in greatest dimension. The nodules are totally submitted in. formalin as follows: E1 four nodules; E2 four nodules; E3 four nodules; E4 two nodules; E5 one nodule. bisected, totally submitted; E6 one nodule; E7-E11 largest nodule, sectioned, totally submitted.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UBLC\",\n    \"reasoning\": \"Initial code: UBLC. Site: Bladder. Histology: Urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA UBLC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site",
      "predicted": "BLCA",
      "ground_truth": "BLCA",
      "correct": true,
      "reasoning": "Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.",
      "idx": 61,
      "timestamp": "2026-01-24T13:29:56.319121"
    },
    {
      "sample_idx": 191,
      "input": "Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: A single lymph node is. negative for malignancy. B. Breast, left, excisional biopsy: Invasive lobular carcinoma,. Nottingham grade 2. Note: The margins are negative for malignancy. C. Breast, posterior lateral margin, biopsy: Focal lobular carcinoma. in situ, negative for invasive carcinoma. Microscopic Description: A. A single lymph node is negative for malignancy. [At the request of some staff o...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFinal Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: A single lymph node is. negative for malignancy. B. Breast, left, excisional biopsy: Invasive lobular carcinoma,. Nottingham grade 2. Note: The margins are negative for malignancy. C. Breast, posterior lateral margin, biopsy: Focal lobular carcinoma. in situ, negative for invasive carcinoma. Microscopic Description: A. A single lymph node is negative for malignancy. [At the request of some staff oncologists and in keeping with the. opinion of some experts in breast pathology, immunohistochemical stains. for keratin were not used on the sentinel lymph node sections in this. case. These stains can be obtained if desired. Our paraffin blocks. are retained for 10 years. (Weaver DL et al. New Engl J Med 364:412,. 2011. Schwartz GF et al. Cancer 94(10):2542,. B. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Nottingham grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Mitotic index: 0 mitoses/ 10 HPFs (1 HPF = 1.96 sq. mm). Tumor size: 1.7 cm. Specimen margins: Negative for malignancy. Carcinoma is 1.2 mm. from the red (anterior) inked margin in block B15. Vessel invasion: Absent. Calcification: Absent. Non-tumorous breast: Fat necrosis, compatible with prior biopsy site. pTNM stage: Tlc NO. Prognostic markers: No previous biopsy here. Markers are available if. needed. Antibody Results Comment. CK5/6. Positive. E-cadherin. Positive. C. Lobular carcinoma in situ is present. Antibody Results Comment. E-cadherin. Negative. Paraffin sections; 10% neutral buffered formalin; Controls stain. appropriately. (A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and controlled in our laboratory and. their performance for. in vitro diagnosis is well described in the medical literature. They have not been cleared. or approved by the FDA.]. Specimen. A. Left axillary sentinel node. B. Left breast biopsy long anterior short superior. C. Posterior lateral margin long anterior short superior. Clinical Information. Cancer diagnosed in. Gross Description. A. Specimen A. is received unfixed labeled axillary sentinel node and. consists of 3 pieces of yellow soft tissue measuring 2.5 x 2 x 1 2.5. x. 1.7 x 1.4 and 2.2 x 1 x 0.5 cm. Sections after fixation. AS-6. B. The specimen is received unfixed in the Transpec container labeled. left breast biopsy and consists of yellow and red piece of soft tissue. measuring 8.5 by 6 by approximately 2.5 cm. The external surface the. specimen is inked as indicated below. Anterior: Red. Posterior Orange. Lateral: Blue. Medial: Green. Superior: Yellow. Inferior: Black. There is a firm area near one end of the specimen measuring 1.5 by 1.7. cm in greatest dimension. A small portion of the tumor is taken for. research purposes. Sections after fixation. RS-16. Specimen C. is received unfixed labeled posterior lateral margin and. consists of a yellow piece of soft tissue measuring 3.4 x 2.5 x 1.5 cm. There is along the short suture on the specimen. The external surface. of the specimen is inked as indicated below. Anterior: Red. Posterior: Orange. Lateral: Blue. Medial: Green. Superior: Yellow. Inferior: Black. Sections after fixation.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "BRCA",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 191,
      "timestamp": "2026-01-24T13:29:56.319132"
    },
    {
      "sample_idx": 447,
      "input": "Gross Description: A. \"Left deep tongue margin.\" 3 fragments of red-tan tissue, each 0.5 cm. All. processed for frozen section. Frozen section control, All processed, A1. B. \"Left tongue (suture towards tongue base).\". Microscopic Description: Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 X 3.0 x 2.0 cm. Laterality: Left. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nGross Description: A. \"Left deep tongue margin.\" 3 fragments of red-tan tissue, each 0.5 cm. All. processed for frozen section. Frozen section control, All processed, A1. B. \"Left tongue (suture towards tongue base).\". Microscopic Description: Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 X 3.0 x 2.0 cm. Laterality: Left. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic type: Squamous cell carcinoma, conventional. Histologic grade: Grade 1. Margins: Uninvolved by invasive or in-situ carcinoma. Lymph-vascular invasion: Absent. Perineural invasion: Absent. Stage: pT2 NO. SUBMANDIBULAR GLAND (LEFT): UNREMARKABLE. LYMPH NODES (LEFT NECK, LEVEL 1): NO NEOPLASM (2 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 2): NO NEOPLASM (7 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 3): NO NEOPLASM (35 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 4): NO NEOPLASM (18 NODES EXAMINED). Diagnosis Details: Tongue (Base, left side): Invasive keratinizing squamous cell carcinoma. Comments: The largest lymph node is 2.2 cm. It has been entirely processed. It exhibits marked follicular. hyperplasia, but there is no metastatic neoplasm. Formatted Path Reports: HEAD & NECK CHECKLIST. Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 x 3.0 x 2.0 cm. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Margins: Uninvolved by invasive or in-situ carcinoma. Lymph-vascular invasion: Absent. Perineural invasion: Absent. Laterality: Left.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 447,
      "timestamp": "2026-01-24T13:29:56.319144"
    },
    {
      "sample_idx": 476,
      "input": "Specimen(s) Received. 1. Nck: RT. perifacial node. 2. Neck: contents right neck - reg. 3. Neck: right hemiglossectomy (short stitch = anterior/ long stitch = medial) - reg. 4. Soft-Tissue: deep margin tongue. Diagnosis. 1. Right perifacial node: - One lymph node, negative for malignancy (0/1). 2. Right neck, dissection: - Metastatic squamous cell carcinoma involving three of forty-four lymph nodes (3/44). a. All involved nodes are level III. b. Largest node involved: 1.8 cm. C. Extracapsular ext...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSpecimen(s) Received. 1. Nck: RT. perifacial node. 2. Neck: contents right neck - reg. 3. Neck: right hemiglossectomy (short stitch = anterior/ long stitch = medial) - reg. 4. Soft-Tissue: deep margin tongue. Diagnosis. 1. Right perifacial node: - One lymph node, negative for malignancy (0/1). 2. Right neck, dissection: - Metastatic squamous cell carcinoma involving three of forty-four lymph nodes (3/44). a. All involved nodes are level III. b. Largest node involved: 1.8 cm. C. Extracapsular extension present. Submandibular gland with mild chronic inflammation, negative for malignancy. 3. Right tongue, hemiglossectomy: - Squamous cell carcinoma, poorly differentiated. a. Maximal tumour dimension: 4.0 cm. b. Tumour thickness: 2.3 cm. c. Perineural invasion present. d. Invasive carcinoma seen focally very close (0.2 cm) to the medial margin. e. Severe squamous dysplasia/carcinoma in-situ (CIS) seen focally close (0.3 cm) to the inferior/lateral margin. f. All other margins negative for malignancy (> 0.5 cm). 4. Deep margin tongue: - Negative for malignancy. Synoptic Data. Specimen Type: Resection:Righ hemiglossectomy. Tumor Site: Tongue. Histologic Type: Squamous cell carcinoma, conventional. Tumor Size: Greatest dimension: 4.0 cm. Tumor thickness: 2.3 cm. Histologic Grade: G3: Poorly differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Present. Additional Pathologic Findings: Carcinoma in situ. Margins: Margins uninvolved by tumor. Margins uninvolved by tumor - Distance of tumor from closest margin: 0.2 cm. Margins: medial. Pathologic Staging (pTNM): pT3: Tumor or lip or oral cavity more than 4 cm in greatest dimension. pN2b: Metastasis in multiple lipsilateral lymph nodes, none more than 6 cm in greatest. dimension for all aerodigestive sites except nasopharynx. Number of regional lymph nodes examined: 44. Number of regional lymph nodes involved: 3. Extra-capsular extension of nodal tumor: Present. pMX: Distant metastasis cannot be assessed. Gross Description. 1. The specimen is labeled with the patient's name and as \"NCK: RT perifacial node\". It consists of a lymph node that. measures 0.9 X 0.8 X 0.5 cm. 1A bisected and submitted in toto. 2. The specimen labeled with the patient's name and as \"neck: Contents right neck -- reg\" consists of an unoriented neck. dissection with overall dimensions of 13.5 cm SI x 6.0 cm AP x 2.5 cm ML. There is no suture orientation; the specimen. grossly appears to include right levels I, II, III and IV, as approximated utilizing the position of the submandibular gland. The internal jugular vein and the sternocleidomastoid muscle are absent. The submandibular gland measures 3.5 x 2.2 x. 2.0 cm and is unremarkable. Multiple lymph nodes ranging from 0,2 to 1.8 cm are identified in multiple levels. Representative sections are submitted. 2A submandibular gland. 2B level I, two lymph nodes. 2C level II, two lymph nodes. 2D-2F level III, one bisected lymph node per block. 2G level III, two lymph nodes. 2H level III, three lymph nodes. 21 level III, four lymph nodes. 2J level III, five lymph nodes. 2K level IV, one bisected fymph node. 2L level IV, three lymph nodes. 2M-2N level IV, four lymph nodes per block. 20-2P level IV, five lymph nodes per block. 3. The specimen is labeled the patient's name and as \"neck: Right hemiglossectomy (short stitch = anterior/long stitch =. medial)- reg\". It consists of a portion of right tongue measuring 6.5 cm AP x 3.4 cm SI X 3.5 cm ML. There is short. anterior, long medial suture orientation. There is a firm tumor involving the lateral and dorsal surf\u00e1ces of the tongue. The. tumor measures 4.0 cm AP x 3.7 cm SI x 2.3 cm ML. The tumor is pale and well delineated, and ulcerates the lateral. mucosal tongue surface. It grossly appears to involve the lateral mucosal margin, is 0.4 cm from the medial margin,. appears to involve the dorsal mucosal margin, is 0.2 cm from the inferior margin, 0.8 cm from the anterior margin, and 0.7. from the posterior margin. The remaining tongue mucosa has white plaques extending postero-superiorly from the tumor. These plaques measure 1.0 cm AP x 1.0 cm SI in aggregate. The surgical margins are painted with silver nitrate; superior. margins are over coated with green dye. The tumor (four pieces) and normal tissue are sampled for tissue banking. Representative sections are submitted. 3A anterior margin. perpendicular section. 3B-31 tumor sampled from anterior to posterior, each pair of blocks a full thickness section, bisected, with the superior. aspect in the first of each pair and the inferior aspect in the second of each pair. 3J mucosal plaques postero-superior to tumor. 3K posterior margin, perpendicular section. 4. The specimen is labeled with the patient's name and as \"soft tissue: Deep margin tongue QS\". It consists of a fragment. of tissue measuring 1.1 X 1.0 x 0.9 cm. The specimen is bisected and submitted in toto for frozen section. The specimen. is subsequently submitted in toto for research. 4A. frozen. section control submitted in toto for research. Quick Section Diagnosis. 4A. Deep tongue margin: negative for malignancy.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 476,
      "timestamp": "2026-01-24T13:29:56.319155"
    },
    {
      "sample_idx": 1034,
      "input": "MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A). LEFT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OF THIRTEEN LYMPH NODES. LESS THAN 1.0 MM FOCUS. NO EXTRANODAL EXTENSION PRESENT. (1/13). (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: Twenty one lymph nodes, no tumor present (0/21). (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTIO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A). LEFT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OF THIRTEEN LYMPH NODES. LESS THAN 1.0 MM FOCUS. NO EXTRANODAL EXTENSION PRESENT. (1/13). (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: Twenty one lymph nodes, no tumor present (0/21). (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT EXTERNAL/ INTERNAL ILIAC HYPOGASTRIC AND OBTURATOR LYMPH NODES - Multiple fragments of fatty tissue. measuring in aggregate 9.0 x 7.0 x 1.5 cm. Dissection reveals multiple possible lymph nodes ranging from 0.6 up to 2.0 cm in their. greatest dimension. Possible lymph nodes are entirely submitted. SECTION CODE: A1, three possible lymph nodes; A2, three possible lymph nodes; A3, one sectioned possible lymph. node; A4, one sectioned possible lymph node; A5, one sectioned possible lymph node; A6, one sectioned possible lymph node;. A7, one sectioned possible lymph node; A8, one sectioned possible lymph node; A9, one sectioned possible lymph node; A10,. A11, one sectioned possible lymph node; A12, A13, one sectioned possible lymph node. (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES - Multiple fragments of fatty. tissue. measuring in aggregate, 9.0 x 8.0 x 2.0 cm. Dissection reveals multiple possible lymph nodes ranging from 0.5 up to 2.5 cm. in their greatest dimension. Possible lymph nodes are entirely submitted in cassettes B1, five possible lymph nodes; B2, five. possible lymph nodes; B3, five possible lymph nodes; B4, four possible lymph nodes; B5, three possible lymph nodes; B6, one. sectioned possible lymph node; B7, one sectioned possible lymph node; B8, one sectioned possible lymph node; B9, one. sectioned possible lymph node; B10, one sectioned possible lymph node; B11, B12, one sectioned possible lymph node; B13, B14,. one sectioned possible lymph node. (C) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. None given. SNOMED CODES. \"Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration.\". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. Page: 3. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (C) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 7 (4+3) WITH TERTIARY GLEASON GRADE 5. COMPONENT. (SEE COMMENT). TUMOR INVADING INTRAPROSTATIC PORTION OF RIGHT SEMINAL VESICLE. TUMOR INVADING FOCALLY RIGHT BLADDER NECK. MARGINS OF RESECTION FREE OF TUMOR. VASCULAR/LYMPHATIC INVASION PRESENT. Left seminal vesicle and segments of vasa deferentia, no tumor present. SEE PREVIOUS REPORT FOR DIAGNOSIS OF PELVIC LYMPH NODES. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right anterolateral, right lateral,. right posterolateral, right posterior, mid posterior, left posterior, left posterolateral and left lateral peripheral zone. The tumor focus. measures. 3.0. x2. cm. in the largest cross-sectional dimension and it is present in three cross sections and extensively in the apex. and. base. regions. The tumor invades focally the right bladder neck. The tumor invades focally the intraprostatic portion of the right. seminal vesicle. The margins of resection are free of tumor. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. (C) PROSTATE AND SEMINAL VESICLES - A prostate, attached right and left seminal vesicles and attached segments of right. and left vasa deferentia. The prostate gland (3.5 x 2.0 x 4.8 cm, 42 gm, postfixation) has the usual shape. The soft tissue present along the left. posterolateral aspects of the prostate appears more abundant than along the right side. A nodule is palpated on the right base. region. Blue ink is applied to surfaces of the prostate (anterior apex and under flap on left posterior surface) which do not represent. the true margin of resection. SECTION CODE: C1-C3, right seminal vesicle and segment of right vas deferens from the base towards the tip; C4-C6,. left seminal vesicle and segment of left vas deferens from the base towards the tip; C7, C8, prostatic base right border; C9-C11,. Page : 4. prostatic base right posterior border; C12-C19, prostatic base central portion; C20-C22, prostatic base left border; C23-C25,. prostatic base left posterior border; C27-C29, apex anterior; C30, C31, apex left; C32, C33, apex posterior; C34, C35, apex right;. C36, C37, detached portions from margin of resection according to specimen radiograph; C38-C49, sections of the three cross. sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked ink green, left surface in red, right surface in yellow and posterior surface in. black. Blue. ink (23-29, 42, 43 and 46) and orange ink (C38, 41, 44-47 and 49) denote surfaces that do not represent the true. margin of resection. SNOMED CODES. Entire report and diagnosis completed by:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\nThe initial code is PCPG. The site is prostate, and the histology is prostatic adenocarcinoma. This matches the TCGA PCPG code.\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"",
      "predicted": "PCPG",
      "ground_truth": "PRAD",
      "correct": false,
      "reasoning": "Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.",
      "idx": 1034,
      "timestamp": "2026-01-24T13:29:56.319167"
    },
    {
      "sample_idx": 1232,
      "input": "FINAL DIAGNOSIS. PART 1: LYMPH NODE, CENTRAL COMPARTMENT, SELECTIVE DISSECTION. A. METASTATIC CARCINOMA IN TWO OUT OF SIX LYMPH NODES (2/6). B. NO EXTRANODAL EXTENSION. PART 2: THYROID, TOTAL THYROIDECTOMY (17 GRAMS). A. PAPILLARY THYROID CARCINOMA, TWO.FOCI (1.2 CM AND 0.5 CM),. B. LARGEST FOCUS: LEFI LOBE, TALL CELL VARIANT WITH EXTRATHYROID EXTENSION; TUMOR. LESS THAN 0.1 CM FROM THE MARGIN. C. CHRONIC LYMPHOCYTIC THYROIDITIS. D. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). E. PATHOLOGIC STAGE: p...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFINAL DIAGNOSIS. PART 1: LYMPH NODE, CENTRAL COMPARTMENT, SELECTIVE DISSECTION. A. METASTATIC CARCINOMA IN TWO OUT OF SIX LYMPH NODES (2/6). B. NO EXTRANODAL EXTENSION. PART 2: THYROID, TOTAL THYROIDECTOMY (17 GRAMS). A. PAPILLARY THYROID CARCINOMA, TWO.FOCI (1.2 CM AND 0.5 CM),. B. LARGEST FOCUS: LEFI LOBE, TALL CELL VARIANT WITH EXTRATHYROID EXTENSION; TUMOR. LESS THAN 0.1 CM FROM THE MARGIN. C. CHRONIC LYMPHOCYTIC THYROIDITIS. D. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). E. PATHOLOGIC STAGE: pT3a N1. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Thyroid cancer. PROCEDURE: Total thyroidectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION THERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.2 cm. HISTOLOGIC TYPE: Papillary carcinoma. TNM DESCRIPTORS: m. PRIMARY TUMOR (pT): REGIONAL LYMPH NODES (pN): pN1a. Number of regional lymph nodes examined: 6. Number of regional lymph nodes involved: 2. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 0.1 mm. LYMPH-VASCULAR INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: CHRONIC LYMPHOCITIC THYROIDITIS.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"THCA\",\n    \"reasoning\": \"Initial code: THCA. Site: Thyroid. Histology: Papillary thyroid carcinoma. This maps to TCGA THCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"ACC\",\n    \"reasoning\": \"Initial code: ACC. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA ACC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site:",
      "predicted": "THCA",
      "ground_truth": "THCA",
      "correct": true,
      "reasoning": "Initial code: THCA. Site: Thyroid. Histology: Papillary thyroid carcinoma. This maps to TCGA THCA.",
      "idx": 1232,
      "timestamp": "2026-01-24T13:29:56.319178"
    }
  ],
  "num_samples": 20,
  "samples": [
    {
      "sample_idx": 1309,
      "input": "Macroscopic examination : Piece weighing 1208 g thymectomy fresh and measuring 19 x 17 x 8 cm. it. extended by a pulmonary resection lingula measuring 8 X 5 X 2 cm When cut , it. is a yellowish white tumor lobulated showing necrotic and remodeling. a small yellowish nodule. Lymph node latero- tracheal top right measuring 1.5 cm in diameter. Microscopic examination : 1) Thymectomy : Many samples were taken ( 1A to 1D ) The tumor has an architecture. lobulated It comprises an epithelial cell proli...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMacroscopic examination : Piece weighing 1208 g thymectomy fresh and measuring 19 x 17 x 8 cm. it. extended by a pulmonary resection lingula measuring 8 X 5 X 2 cm When cut , it. is a yellowish white tumor lobulated showing necrotic and remodeling. a small yellowish nodule. Lymph node latero- tracheal top right measuring 1.5 cm in diameter. Microscopic examination : 1) Thymectomy : Many samples were taken ( 1A to 1D ) The tumor has an architecture. lobulated It comprises an epithelial cell proliferation primarily. fusiform These cells are grouped together in small bundles . They are arranged. also small beaches. Lymphocyte contigent is also abundant enough. mixed with epithelial contigent. Presence of some beaches fibrosis with remodeling. inflammatory with tablecloths foamy histiocytes . No outbreak of differentiation. medulla. Presence of a range of tumor necrosis Presence of some clear spaces. perivascular (1B) . The tumor is highly infiltrative and invades the lung parenchyma. (1E) The limits of resection inked in green appear microscopically healthy. Some areas appear much richer in epithelial cells with a. scarcity of accompanying lymphocytes. After immunohistochemistry epithelial cells express cytokeratin KL1. and focally CD20. However, they are negative for CD5 and CD117. 2) Lymph node lat\u00e9rotrach\u00e9al top right : This is a little modified lymph node No histological evidence of. malignancy. Conclusion : Type AB thymoma in 19 cm major axis , with widely invasive invasion in the. lung parenchyma stage 3 according to the classification of Masaoka resection. surgical complete.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"THYM\",\n    \"reasoning\": \"Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA",
      "predicted": "THYM",
      "ground_truth": "THYM",
      "correct": true,
      "reasoning": "Initial code: THYM. Site: Thymus. Histology: Thymoma. This maps to TCGA THYM.",
      "idx": 1309,
      "timestamp": "2026-01-24T13:29:56.318934"
    },
    {
      "sample_idx": 228,
      "input": "Result date: Date Collected: SPECIMEN A: CERVIX BX. SPECIMEN B: BLADDER BX. CLINICAL HISTORY: SPECIMENS SUBMITTED: A. CERVIX BX. B. BLADDER BX. DIAGNOSIS: CERVIX; BIOPSY: INVASIVE, POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. ANGIOLYMPHATIC INVASION NOT IDENTIFIED. SPECIMEN IS NEARLY ENTIRELY INVASIVE CARCINOMA, DEPTH OF INVASION CANNOT BE. DETERMINED, BUT TUMOR MEASURES 1.0 CM IN MICROSCOPIC SECTION. BLADDER, BIOPSY: SQUAMOUS METAPLASIA WITHOUT DYSPLASIA. NEGATIVE FOR CARCINOMA. ABUNDANT BLOO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nResult date: Date Collected: SPECIMEN A: CERVIX BX. SPECIMEN B: BLADDER BX. CLINICAL HISTORY: SPECIMENS SUBMITTED: A. CERVIX BX. B. BLADDER BX. DIAGNOSIS: CERVIX; BIOPSY: INVASIVE, POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA. ANGIOLYMPHATIC INVASION NOT IDENTIFIED. SPECIMEN IS NEARLY ENTIRELY INVASIVE CARCINOMA, DEPTH OF INVASION CANNOT BE. DETERMINED, BUT TUMOR MEASURES 1.0 CM IN MICROSCOPIC SECTION. BLADDER, BIOPSY: SQUAMOUS METAPLASIA WITHOUT DYSPLASIA. NEGATIVE FOR CARCINOMA. ABUNDANT BLOOD CLOT WITH EXFOLIATED BUT BENIGN APPEARING EPITHELIAL CELLS. BIOPSY CONTAINS NO MUSCLE CONSISTENT WITH MUSCULARIS PROPRIA. I. INTRA-OPERATIVE DIAGNOSIS: Cervical biopsy: Invasive squamous cell carcinoma. CLINICAL INFORMATION: -year old female with large cervical lesion consistent with cervical. cancer. GROSS DESCRIPTION: There are two containers, each labeled with the patient's name and medical. record number. Rendering Diagnostician: Completed Action List:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Squamous cell carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"CCRC\",\n    \"reasoning\": \"Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BL",
      "predicted": "CCRC",
      "ground_truth": "CESC",
      "correct": false,
      "reasoning": "Initial code: CCRC. Site: Cervix. Histology: Invasive squamous cell carcinoma. This maps to TCGA CCRC.",
      "idx": 228,
      "timestamp": "2026-01-24T13:29:56.318959"
    },
    {
      "sample_idx": 51,
      "input": "SURGICAL PATHOL 03Y REPOR. DIAGNOSIS: RADICAL CYSTOPROSTATECTOMY, BILATERAL PELVIC LYMPH NODE DISSECTION AND. URINARY DIVERSION (T-POUCH) : RIGHT DISTAL URETER (A) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT DISTAL URETER (B) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. - NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. PARA-AO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSURGICAL PATHOL 03Y REPOR. DIAGNOSIS: RADICAL CYSTOPROSTATECTOMY, BILATERAL PELVIC LYMPH NODE DISSECTION AND. URINARY DIVERSION (T-POUCH) : RIGHT DISTAL URETER (A) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT DISTAL URETER (B) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: BENIGN URETER. - NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. PARA-AORTIC PROXIMAL LIMITS LYMPH NODES (C) : FROZEN SECTION DIAGNOSIS: - BENIGN. FINAL DIAGNOSIS: - NO MALIGNANCY IDENTIFIED IN TWO LYMPH NODES EXAMINED (0/2). APICAL URETHRAL MARGIN (D) : FROZEN SECTION DIAGNOSIS: NO HIGH GRADE ATYPIA OR TUMOR IDENTIFIED. FINAL DIAGNOSIS: - SCANT MALIGNANT CELLS IN PERIPHERAL SOFT TISSUE OF URETHRA (SEE COMMENT). BENIGN URETHRAL MUCOSA. BLADDER AND PROSTATE (E) : BLADDER: - INVASIVE POORLY DIFFERENTIATED UROTHELIAL CARCINOMA WITH FOCAL SIGNET. RING CELL COMPONENT (3.! X 3.0 x 2.2 CM GROSS DIMENSIONS), , GRADE 4/4, GROSSLY. AND MICROSCOPICALLY EXTENDING THROUGH ANTERIOR AND RIGHT AND LEFT. LATERAL BLADDER WALLS TO INVOLVE PERIVESICAL SOFT TISSUE. LYMPHOVASCULAR INVASION IDENTIFIED. - UROTHELIAL CARCINOMA IN SITU (FLAT LESION) IDENTIFIED INCLUDING PAGETOID. INVOLVEMENT OF TRIGONE. - RANDOM BLADDER MUCOSA EXHIBITING FOCI OF MODERATE UROTHELIAL DYSPLASIA. AND REACTIVE ATYPIA. INKED BLADDER RESECTION MARGINS, FREE OF MALIGNANCY. PROSTATE: - INVASIVE UROTHELIAL CARCINOMA INVOLVING PERIPROSTATIC SOFT TISSUE OF ENTIRE. PROSTATE, WITH INVASION OF PROSTATIC STROMA AND LYMPHOVASCULAR SPACE. INVOLVEMENT. - INVASIVE UROTHELIAL CARCINOMA INVOLVING SOFT TISSUE AROUND SEMINAL. VESICLES. - UROTHELIAL CARCINOMA INVOLVING INKED RIGHT POSTERIOR PERIPROSTATIC. SOFT TISSUE MARGIN. RARE FOCI OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN II). NO PROSTATIC ADENOCARCINOMA IDENTIFIED. RIGHT PARACAVAL LYMPH NODES (F) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF THREE LYMPH NODES EXAMINED. (3/3). SURGICALPATHOLOG REPORT. LEFT PARA-AORTIC LYMPH NODES (G) : METASTATIC CARCINOMA IDENTIFIED IN ONE OF THREE LYMPH NODES EXAMINED (1/3). RIGHT COMMON ILIAC LYMPH NODES (H) : METASTATIC CARCINOMA IDENTIFIED IN TWO OF TWO LYMPH NODES EXAMINED. (2/2). LEFT COMMON ILIAC LYMPH NODES (I) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF SEVEN LYMPH NODES EXAMINED. RIGHT LYMPH NODES OF CLOQUET (J) : NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE EXAMINED (0/1). RIGHT EXTERNAL ILIAC LYMPH NODES (K) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF FOUR LYMPH NODES EXAMINED. (3/4) [LARGEST POSITIVE LYMPH NODE 2.9 CM]. RIGHT OBTURATOR/HYPOGASTRIC LYMPH NODES (L) : METASTATIC CARCINOMA IDENTIFIED IN SIX OF NINE LYMPH NODES EXAMINED (5/8). LEFT EXTERNAL ILIAC LYMPH NODES (M) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF SEVEN LYMPH NODES EXAMINED (2/7). LEFT LYMPH NODE OF CLOQUET (N) : NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE EXAMINED (0/1). LEFT OBTURATOR/HYPOGASTRIC LYMPH NODES (O) : METASTATIC CARCINOMA IDENTIFIED IN FOUR OF FOUR LYMPH NODES EXAMINED (4/4). RIGHT PRESCIATIC LYMPH NODES (P) : METASTATIC CARCINOMA IDENTIFIED IN THREE OF THREE LYMPH NODES EXAMINED. (3/3). PRESACRAL LYMPH NODES (Q) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF FOUR LYMPH NODES EXAMINED (2/4). LEFT PRESCIATIC LYMPH NODES (R) : - METASTATIC CARCINOMA IDENTIFIED IN TWO OF FOUR LYMPH NODES EXAMINED (2/4). RIGHT PROXIMAL URETER (S) : - BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT PROXIMAL URETER (T) : BENIGN URETER. NO UROTHELIAL DYSPLASIA OR MALIGNANCY IDENTIFIED. LYMPH NODE SUMMARY: METASTATIC CARCINOMA IDENTIFIED IN TOTAL OF 30 OUT. 53 LYMPH NODES EXAMINED (30/53). PATHOLOGIC TNM STAGE: pT4aN2MX. Verified: COMMENT: Dr. was notified of the disprepancy in the frozen section diagnosis and. final diagnosis for the apical urethral margin,. SPECIMEN SOURCE: A: \" Right distal ureter\". B: \"Left distal ureter\". C: \"Para aortic proximal limits lymph nodes - FS\". D: \"Apical urethral margin\". E: \"Bladder + prostate\". F: \"Right para caval lymph nodes\". G: \"Left para aortic lymph nodes\". H: \"Right common iliac lymph nodes\". I: \"Left common iliac lymph nodes\". J: \"Right lymph nodes of cloquet\". K: \"Right external iliac lymph nodes\". L: \"Right obturator/hypogastrio lymph nodes\". M: \"Left external iliac lymph nodes\". N: \"Left lymph node of cloquet\". O: \"left obturator/hypogastric lymph nodes\". P: \"Right pre sciatic lymph nodes\". Q: \"Pre sacral lymph nodes\". R: \"Left pre sciatic lymph nodes\". S: \"Right proximal ureter\". T: \"Left proximal ureter\". CLINICAL INFORMATION: Pre-Op Dx: Bladder cancer, TCC. GROSS EXAMINATION: A: The specimen is received fresh from the O.R. and labeled \"Right distal ureter\". It consists of a segment of ureter measuring 0.4 cm in length by 0.2 cm in. diameter. The specimen is submitted entirely for frozen section in cassette AFS. B: The specimen is received fresh from the O.R. and labeled \"Left distal ureter\". It consists of a segment of ureter measuring 0.4 cm in length by 0.2 cm in. diameter. The specimen is submitted entirely for frozen section in cassette BFS. C: The specimen is received fresh from the O.R. and labeled \"Para aortic proximal. limits lymph nodes - FS\". It consists of a segment of soft tan-yellow adipose. tissue measuring 2 x 1.1 x 0.8 cm. Multiple lymph nodes are identified and. submitted entirely for frozen section in cassette CFS. D: The specimen is received fresh from the O.R. and labeled \"Apical urethral. margin\". It consists of two fragments of soft tan-pink tissue measuring in. aggregate 1.4 x 0.4 x 0.4 cm. The specimen is submitted entirely for frozen. section in cassette DFS. E: The specimen is received fresh from the O.R. and labeled \"Bladder + prostate\". It consists of a cystoprostatectomy specimen measuring overall 14 x 10.5 x 4.8 cm. The peritoneum measures 15 x 11 x 0.1 cm and is smooth, glistening and freely. mobile. The non-peritonealized surface is inked black with red ink superimposed. over the right side of the prostate. The specimen is opened anteriorly along the. prostatic urethra. The bladder measures 6 x 4 x 3.5 cm with a wall thickness of. 0.8 cm. The bilateral ureterovesical junctions are identified and are patent. The. ureters are then opened. The right attached ureter measures 5 cm in length by 0.5. cm in circumference and the left attached ureter measures 4 cm in length by 0.5 cm. in circumference. Both the right and left ureters are grossly unremarkable. The. CHDATAR DATEA thav REPORT. Gollected. anterior wall of the bladder is replaced by a tan-red, firm and ulcerated mass. that extends from the anterior wall to both the right and left lateral aspects of. the bladder while sparing the ureterovesical junctions and trigone area. This mass. measures 3.5 x 3 x 2.2 cm and appears to grossly involve the full thickness of the. bladder wall with gross extension into the perivesical fat anteriorly and on both. the right and left aspects of the bladder. The wall thickness of the involved. bladder measures 2.2 cm. The remaining bladder mucosa is tan-pink and slightly. edematous. The prostate measures 4 x 3.5 x 3.5 cm. The prostatic urethra measures. 3 cm in length by 2 cm in circumference and is grossly unremarkable. The. verumontanum measures 1 x 0.3 x 0.3 cm. The right seminal vesicle measures 3 x 1.5. x 1 cm, and the left seminal vesicle measures 3 x 1.5 x 1 cm. Both the seminal. vesicles are grossly unremarkable. Palpating the perivesical fat shows no. additional nodules. Representative sections are submitted in 27 cassettes. F: The specimen is received in formalin and labeled \"Right para caval lymph. nodes\" It consists of a segment of soft tan-yellow fibroadipose tissue measuring. 4. x 2 x 1 cm. Two lymph nodes are identified, the largest measuring 2 cm in. greatest dimension. The specimen is submitted entirely in three cassettes. G: The specimen is received in formalin and labeled \"Left para aortic lymph. nodes\". It consists of a single segment of soft tan-yellow fibroadipose tissue. measuring 3.5 x 1 x 1 cm. One lymph node is identified measuring 1 cm in greatest. dimension. The specimen is submitted entirely in one cassette. H: The specimen is received in formalin and labeled \"Right common iliac lymph. nodes\" It consists of two segments of soft tan-yellow fibroadipose tissue. measuring in aggregate 6 x 3 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 3.8 cm in greatest dimension. The specimen is submitted entirely. in six cassettes. I: The specimen is received in formalin and labeled \"Left common iliac lymph. nodes\" It consists of multiple segments of soft tan-yellow fibroadipose tissue. measuring 4 x 1.5 x 2 cm in aggregate. Multiple lymph nodes are identified, the. largest measuring 1.8 cm in greatest dimension. The specimen is submitted entirely. in three cassettes. J: The specimen is received in formalin and labeled \"Right lymph nodes of. cloquet\" It consists of a single segment of soft tan-yellow fibroadipose tissue. measuring 2 x 1.1 x 0.7 cm. One lymph node is identified measuring 1.5 cm in. greatest dimension. The specimen is bisected and submitted entirely in one. cassette. K: The specimen is received in formalin and labeled \"Right external iliac lymph. nodes\". It consists of multiple segments of soft tan-yellow fibroadipose tissue. measuring in aggregate 5 x 3.5 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 3 cm in greatest dimension. The specimen is submitted entirely. in six cassettes. L: The specimen is received in formalin and labeled \"Right obturator/hypogastric. lymph nodes\" It consists of multiple segments of soft tan-yellow fibroadipose. tissue measuring in aggregate 6.5 x 4 x 2 cm. Multiple lymph nodes are identified,. the largest measuring 4 cm in greatest dimension. The specimen is submitted. entirely in eight cassettes. M: The specimen is received in formalin and labeled \"Left external iliac lymph. nodes\". It consists of multiple pieces of soft tan-yellow fibroadipose tissue. measuring in aggregate 4 x 3 x 3 cm. Multiple lymph nodes are identified, the. largest measuring 2 cm in greatest dimension. The specimen is submitted entirely. in seven cassettes. colected. N: The specimen is received in formalin and labeled \"Left lymph node of cloquet\". It consists of a single segment of tan-yellow fibroadipose tissue measuring 1.5 x 1. x 0.8 cm. One lymph node is identified measuring 1.3 cm in greatest dimension. The specimen is submitted entirely in one cassette. O: The specimen is received in formalin and labeled \"left obturator/hypogastrio. lymph nodes\". It consists of multiple segments of soft tan-yellow fibroadipose. tissue measuring in aggregate 6 x 3 x 1 cm. Multiple lymph nodes are identified,. the largest measuring 4.6 cm in greatest dimension. The specimen is submitted. entirely in six cassettes. P: The specimen is received in formalin and labeled \"Right pre sciatic lymph. nodes\" It consists of multiple fragments of soft tan-yellow fibroadipose tissue. measuring in aggregate 2 x 1 x 0.6 cm. Two lymph nodes are identified, the largest. measuring 0.5 cm in greatest dimension. The specimen is submitted entirely in one. cassette. Q: The specimen is received in formalin and labeled \"Pre sacral lymph nodes\". It. consists of a single piece of soft tan-pink fibroadipose tissue measuring 4.8 x 2.5. x 0.8 cm. No discrete masses are identified. The specimen is submitted entirely. in three cassettes. R: The specimen is received in formalin and labeled \"Left pre sciatic lymph. nodes\" It consists of multiple fragments of soft tan-yellow fibroadipose tissue. measuring in aggregate 2.5 x 1.5 x 1 cm. Multiple lymph nodes are identified, the. largest measuring 0.4 cm in greatest dimension. The specimen is submitted entirely. in one cassette. S: The specimen is received in formalin and labeled \"Right proximal ureter\". It. consists of a segment of ureter with surrounding adipose tissue measuring overall. 1.5 x 1 x 0.4 cm. The ureter measures 0.8 cm in length by 0.2 cm in average. diameter. Two metallic clips are present equidistant from both ends. The specimen. is bisected and submitted entirely in one cassette. T: The specimen is received in formalin and labeled \"Left proximal ureter\". It. consists of a segment of ureter with attached adipose tissue measuring overall 1.5. x. 1 x 0.6 cm. The ureter measures 1 cm in length by 0.2 cm in average diameter. Two metallic clips are present along one end of the ureter. The end opposite the. ureter is inked black and the specimen is trisected and submitted entirely in one. cassette. SECTIONS. AFS: frozen section, right distal ureter. BFS: frozen section, left distal ureter. CFS: frozen section, para-aortic proximal limits lymph nodes. DFS : frozen section, apical ureteral margin. E1-3. bladder and prostate; right anterior and lateral wall of bladder. E4-6: left anterior and lateral wall of bladder. E7 : dome. E8 : posterior wall of bladder. E9 : right ureterovesical junction. E10 : left ureterovesical junction. E11 : trigone. E12 : urethral junction. E13 : right perivesical fat for possible lymph nodes. E14 : left perivesical fat for possible lymph nodes. E15 : prostate, right apex anterior. E16 : prostate, right apex posterior. E17 : prostate, left apex anterior and posterior. E18 : prostate, right mid anterior. SURGICAL PATHOLOCYREROR. E19 : prostate, right mid posterior. E20 : prostate, left mid anterior. E21 : prostate, left mid posterior. E22 : prostate, right base anterior. E23 : prostate, right base posterior. E24 : prostate, left base anterior. E25 : prostate, left base posterior. E26 : right seminal vesicle junction with prostate. E2 : left seminal vesicle junction with prostate. F1 2 : right paracaval lymph nodes; largest lymph node, bisected. F3. one lymph node, bisected. G: left para-aortic lymph nodes - all embedded. H1-4: right common iliac lymph nodes; one large lymph node quadrisected. H5: one lymph node, bisected. H6: remaining tissue. I1: left common iliac lymph nodes; multiple lymph nodes. I2,3: remaining tissue. right lymph nodes of Cloquet; one lymph node, bisected. K1,2. right external iliac lymph nodes; largest lymph node, bisected. K3. one lymph node, bisected. K4. one lymph node, bisected. K5,. remaining tissue. L1-4: right obturator/hypogastric lymph nodes; one large lymph node. quadrisected. L5: one lymph node, bisected. L6: one lymph node, bisected. L7: : three lymph nodes. L8: remaining tissue. M1 : left external iliac lymph nodes; largest lymph node, bisected. M2 : one lymph node, bisected. M3 : one lymph node, bisected. M4: multiple lymph nodes. M5-7: remaining tissue. N: left lymph node of Cloquet; one lymph node, bisected. 01-4: left obturator/hypogastric lymph node; one large lymph node. quadrisected. 05: one lymph node, bisected. 06. remaining tissue. P: right presciatic lymph nodes - all embedded. Q1-3: presacral lymph nodes - all embedded. R: left presciatic lymph nodes - all embedded. S: right proximal ureter - all embedded. left proximal ureter - all embedded. INTRAOPERATIVE FROZEN CONSULTATION: AFS Right distal ureter: no high grade atypia or tumor identified. BFS: Left distal ureter: - no high grade atypia or tumor identified. CFS: Para-aortic proximal limits lymph nodes: - benign. DFS: Apical ureteral margin: no high grade atypia or tumor identified. MICROSCOPIC EXAMINATION: A-C: See final microscopic-diagnoses. D: Permanent sections of the apical urethral margin show single and small clusters. of malignant cells in the periurethral soft tissue, particularly around and within. muscle bundles. A review of the original frozen sections shows rare atypical. cells, that when viewed in context with the main tumor in the bladder and the. permanent sections of the urethral margin are interpreted as representing. carcinoma. The urethral mucosa itself and the immediate underlying support tissue. shows no evidence of urothelial dysplasia or malignancy. E: Sections of the bladder show an invasive poorly differentiated urothelial. carcinoma composed of cells with enlarged hyperchromatic nuclei with coarse. chromatin and prominent central macronucleoli (E1-6) Some of the tumor cells. display signet ring cell features. The tumor invades through the muscularia. propria into the perivesical fat and involves the entire anterior bladder wall as. well as the right and left lateral bladder wall regions. Urothelial carcinoma in. situ (flat lesion) is identified in association with the invasive carcinoma (E4,5). as well as in the trigone region where it is represented by pagetoid spread. Other. random sections of bladder mucosa exhibit foci of moderate urothelial dysplasia and. areas of reactive atypia. The inked bladder resection margins are free of. malignancy. Sections of the prostate show extensive urothelial carcinoma involving. periprostatic soft tissue (E17-23,25) with invasion of prostatic stroma from \"the. outside in\" (E18-21) Lymphovascular invasion is seen (E21,25). Tumor extends to. the right posterior inked margin of the prostate (E19,23) . Tumor involves tissue. around the seminal vesicles without involving the seminal vesicles themselves. (E26,27) The uninvolved prostate shows cystic atrophy and rare foci of high grade. prostatic intraepithelial neoplasia (PIN II) No prostatic adenocarcinoma is seen. F-T: See final microscopic-diagnosis.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Ureter. Histology: Urothelial carcinoma. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Urothelial carcinoma. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Prostate. Histology: Urothelial carcinoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"STAD\",\n    \"reasoning\": \"Initial code: STAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA STAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"COAD\",\n    \"reasoning\": \"Initial code: COAD. Site: Colon. Histology: Adenocarcinoma. This maps to TCGA COAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LGG\",\n    \"reasoning\": \"Initial code: LGG. Site: Brain. Histology: Glioblastoma. This maps to TCGA LGG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"GBM\",\n    \"reasoning\": \"Initial code: GBM. Site: Brain. Histology: Glioblastoma",
      "predicted": "UROS",
      "ground_truth": "BLCA",
      "correct": false,
      "reasoning": "Initial code: UROS. Site: Ureter. Histology: Urothelial carcinoma. This maps to TCGA UROS.",
      "idx": 51,
      "timestamp": "2026-01-24T13:29:56.318974"
    },
    {
      "sample_idx": 563,
      "input": "Clinical History/Diagnosis: Left Renal Tumor. Source of Specimen(s): 1: left Kidney resection with Adrenal gland. 2: left paraaortic lymph nodes. Gross Description: Received in two parts. Source of Tissue: 1. Labeled # 1, \"left kidney with mass, portion of. adrenal and hilar lymph node\". Frozen Section Diagnosis: 1FS- RENAL CELL CARCINOMA. Gross Description: Received fresh in a container labeled left kidney with mass, portion. of adrenal and hilar lymph. node\". It consists of a 720 gram left rad...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nClinical History/Diagnosis: Left Renal Tumor. Source of Specimen(s): 1: left Kidney resection with Adrenal gland. 2: left paraaortic lymph nodes. Gross Description: Received in two parts. Source of Tissue: 1. Labeled # 1, \"left kidney with mass, portion of. adrenal and hilar lymph node\". Frozen Section Diagnosis: 1FS- RENAL CELL CARCINOMA. Gross Description: Received fresh in a container labeled left kidney with mass, portion. of adrenal and hilar lymph. node\". It consists of a 720 gram left radical nephrectomy consisting of. left kidney measuring 15.0 X 8.0 x 7.0 cm with attached fat ranging from. 0.1 up to 3.5 cm from point of attachment. At the hilum the segment of. ureter measures 9.0 X 0.5 cm with a pin point Jumen and no suspicious. areas. The vessels are also normal. At the superior aspect of the hilum. there is a portion of adrenal gland measuring 2.8 X 1.5 X 0.4 cm. The. adrenal gland is normal. The kidney is bivalved disclosing a large soft. mass centrally in the kidney that measures 9.0 X 6.0 X 7.0 cm. The kidney. is orangish yellow to red in color and centrally within the mass is a. large cyst containing gelatinous, necrotic material. The tumor comprises. approximately 60% of the nephrectomy and markedly distorts the calyceal. system. The mass is pushing on the capsule in multiple areas however no. gross invasion is found. Multiple representative sections of the tumor in. relationship to the capsule and overlying fat will be submitted for. histological impression. Elsewhere, adjacent to the tumor the kidney is. normal appearing with the usual cortical-medullary junctions. Dissection. through the fat and the hilum discloses moist glistening adipose tissue. and no nodal tissue is found. Fresh tissue is procured and sent for. Cytogenetics and Gross Photos are taken. Designation of Sections: 1A - vascular and ureter margins, 1B- adrenal. gland, 1C- tumor pushing on hilum, 1D-1E- tumor pushing on pelvis, 1F-1H-. tumor in relationship to capsule and fat, 1I-1J- tumor in relationship to. adjacent normal parenchyma, 1K-1L- perinephric fat. Source of Tissue: 2. Labeled # 2, \"left para aortic lymph nodes\". Gross Description: Received fresh in a container labeled 'left para aortic lymph nodes\". It consists of multiple. fragments of fibroadipose tissue measuring 4.0 X 4.0 X 1.5 cm. Dissection. through the tissue discloses a few normal appearing and fatty nodes. ranging from 0.1 up to 2.5 cm. Designation of Sections: 2A-2D- - multiple single lymph nodes and fat, 2E-. single bisected lymph node, 2F- single bisected node. Final Diagnosis: 1. Kidney and adrenal, left, radical nephrectomy and partial. adrenalectomy: - Renal cell carcinoma, convential type, Fuhrman grado III (9 cm). - The tumor appears confined to the kidney. - Adrenal gland, No tumor seen. Note: The tumor shows admixed areas of low grade clear cell carcinoma, and. higher grade tumor with abundant granular cytoplasm (both can be seen in. convential type renal cell carcinoma). 2. Left para aortic lymph nodes, excision: - No tumor seen in sixteen lymph nodes (0/16). - pT2NOMx. FCGTL: Chromo15, Chrom45, Interp. Procedures/Addenda. FC Cytogenetics Solid Tumor. Interpretation. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Clear Cell Renal Cell Carcinoma. KARYOTYPE: Abnormal mosaic male karyotype: 38. 44,XY,del(3)(p13),+mar[cp4)/46,XY[13). RESULTS: The renal tumor was harvested after six and eleven days in. culture. Seventeen metaphases were found in a scan of twelve slides. The. chromosomes from these metaphases were counted and analyzed, and four of. these metaphases were karyotyped by G-banding. Four cells had between 38. and 44 chromosomes and contained a deletion in the p arm of chromosome 3. as well as a marker chromosome. Thirteen cells had a modal chromosome. number of 46 and appeared to have a normal karyotype. The deletion in 3p. is characteristic of clear cell renal cell carcinoma.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA",
      "predicted": "KIRC",
      "ground_truth": "KIRC",
      "correct": true,
      "reasoning": "Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma. This maps to TCGA KIRC.",
      "idx": 563,
      "timestamp": "2026-01-24T13:29:56.318987"
    },
    {
      "sample_idx": 501,
      "input": "MEDICAL RECORD. Surgical. Pathology Report Carenoma renal all deronophable. PROCEDURE DATE: SEX: M. SIGN-OUT DATE: ATTENDING: REQUESTING: CONTACT NO: ROOM: COPIES TO: DIAGNOSIS: Kidney, right, radical nephrectomy: Renal cell carcinoma, chromophobe cell type, Fuhrman nuclear. grade II; no capsular invasion seen; vascular, urteral and inked surgical margins of resection are free of tumor; no. tumor seen in three lymph nodes (0/3); see note. NOTE: Kidney Nephrectomy Summary Table Macroscopic. Speci...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMEDICAL RECORD. Surgical. Pathology Report Carenoma renal all deronophable. PROCEDURE DATE: SEX: M. SIGN-OUT DATE: ATTENDING: REQUESTING: CONTACT NO: ROOM: COPIES TO: DIAGNOSIS: Kidney, right, radical nephrectomy: Renal cell carcinoma, chromophobe cell type, Fuhrman nuclear. grade II; no capsular invasion seen; vascular, urteral and inked surgical margins of resection are free of tumor; no. tumor seen in three lymph nodes (0/3); see note. NOTE: Kidney Nephrectomy Summary Table Macroscopic. Specimen Type: Radical nephrectomy. Laterality: Right. Tumor Size: 5x5x4cm. Focality: Unifocal. Macro Extent of Tumor: Confined to kidney, upper pole, laterally. Microscopic. Histologic Type: Renal cell carcinoma, chromophobe cell type. Histologic Grade: Fuhrman nuclear grade II. Extent of Invasion. Primary Tumor(pT): pT1b. Regional Lymph Nodes(pN): pNO. Distant Metastisis(pM). pMx. Margins: Vascular, ureteric and surgical margins of resection are free of tumor. CLINICAL INFORMATION: Brief Clinical History: yo male with 4. .5cm right renal mass,. incidental diagnosis, sporadic tumor Requestor Name. File in Section 3: Tissue Examination. MEDICAL RECORD. Requestor Phone/Pager: Allocate Order to Protocol: PROCEDURE: Operative Findings: n/a Post-Operative Diagnosis: same Pre-Operative. Diagnosis: right renal mass. SPECIMENS SUBMITTED: 1. KIDNEY, RIGHT. GROSS DESCRIPTION: Received fresh from the OR labeled with the patient's name, medical record number,. and \"right kidney and adrenal\" is a specimen that consists of a radical nephrectomy specimen with attached. adrenal gland entirely measuring, in total, 15 x 9 x 6 cm. The specimen is inked in black and bisected revealing. a. 5 x 5 x 4 cm tumor mass with a brown/yellow cut surface. 40% of the tumor mass is procured for. along with. representative sections of normal adrenal and kidney. The procurement is performed by. on. At. the specimen received matches the above description and weighs 240 grams. The kidney. is further serially sectioned. The tumor is towards the upper half of the kidney laterally towards the upper lateral. pole. The renal capsule appears to be focally adherent over the tumor. The adrenal is well away from the tumor. and the fat around the adrenal is not apposed to the tumor. Sections are submitted as follows: : Vascular and ureteral cut margins. and C: Sections from areas suspicious for capsule adherence including up to inked surgical margin. :: Representative section from center of tumor. Section of tumor including renal pelvic fat. Tumor with adjacent apparent uninvolved kidney. Tumor including kidney and suprarenal fat. Adrenal with surrounding fat. Cection from grossly normal kidney. J and K: Probable lymph node candidates from the renal hilum. Gross dictated by. No consultants. MEDICAL RECORD. Nam. Date OT report:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"KIRC\",\n    \"reasoning\": \"Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to",
      "predicted": "KIRC",
      "ground_truth": "KICH",
      "correct": false,
      "reasoning": "Initial code: KIRC. Site: Kidney. Histology: Renal cell carcinoma, chromophobe cell type. This maps to TCGA KIRC.",
      "idx": 501,
      "timestamp": "2026-01-24T13:29:56.319000"
    },
    {
      "sample_idx": 457,
      "input": "DIAGNOSIS. (A) TEETH: (B) LEFT NECK DISSECTION, LEVEL I \"A\": Teeth identified, gross identification only. One lymph node, no tumor present (0/1). (C) LEFT PARTIAL GLOSSECTOMY:: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 7.2 cm in largest dimension. Invasion: Present, depth 0.6 cm. Tumor Border: infiltrative. Perineural Invasion: Absent. Vascular Invasion: Absent. Lymphocyte Infiltration: Absent. Mucosal Margin: (en-face) Negative for invasive carc...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nDIAGNOSIS. (A) TEETH: (B) LEFT NECK DISSECTION, LEVEL I \"A\": Teeth identified, gross identification only. One lymph node, no tumor present (0/1). (C) LEFT PARTIAL GLOSSECTOMY:: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 7.2 cm in largest dimension. Invasion: Present, depth 0.6 cm. Tumor Border: infiltrative. Perineural Invasion: Absent. Vascular Invasion: Absent. Lymphocyte Infiltration: Absent. Mucosal Margin: (en-face) Negative for invasive carcinoma. Deep Margin: (radial) Negative for invasive carcinoma. Dysplasia at Margin: Absent. (D) LEFT NECK DISSECTION, LEVEL I: Seven lymph nodes, no tumor present (0/7). Salivary tissue, no tumor present. (E) LEFT NECK DISSECTION, LEVEL II: Twenty-two lymph nodes, no tumor present (0/22). (F) LEFT NECK DISSECTION, LEVEL III: Ten lymph nodes, no tumor present (0/10). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TEETH - Multiple fragments of white-tan teeth. The specimen is for gross examination only. (B) LEFT NECK DISSECTION, LEVEL I \"A\" - A 0.9 X 0.5 X 0.4 cm lymph node. The specimen is submitted entirely in cassette. B. (C) LEFT PARTIAL GLOSSECTOMY - Specimen consists of a portion of tongue (7.5 X 6.7 X 4.5 cm) with a centrally placed. exophytic verrucous tumor (7.2 X 6.3 X 2.5 cm). The closest mucosal margin is posteriorly towards the base of tongue (0.4 cm). The tumor appears to possibly superficially invade the muscle of the tongue, but the deep margin is widely free of tumor. The. lingual nerve is identified by the surgeon and is grossly unremarkable. INK CODE: Black - deep margin. SECTION CODE: C1, superior/anterior mucosal margin for frozen section; C2, superior mid, mucosal margin for. frozen. section; C3, superior posterior mucosal margin for frozen section; C4, base of tongue, medial mucosal margin for frozen. section; C5, base of tongue, lateral mucosal margin for frozen section; C6, lateral posterior mucosal margin for frozen section;. C7, lateral mid mucosal margin for frozen section; C8, lateral anterior mucosal margin for frozen section; C9, anterior mucosal. margin. for frozen section; C10, representative sections of the lingual for frozen section; C11, representative section of tumor. with closest deep margin for frozen section; C12-C20. representative sections of tumor with underlying tongue, submitted. anterior to posterior (deep margin in C13-C15). FS/DX: NO TUMOR PRESENT AT MARGINS. (D) LEFT NECK DISSECTION LEVEL I - An unoriented, tan-pink fragment of fibrofatty tissue (7.0 X 6.5 X 2.5 cm). Dissection. reveals a tan, grossly unremarkable submandibular gland (6.0 X 5.0 X 2.5 cm). Nine lymph nodes are identified, ranging from. (0.2 X 0.1 X 0.1 cm to 2.0 X 1.5 X 1.0 cm). SECTION CODE: D1, five lymph nodes: D2 three lymph nodes; D3, D4, one lymph node, serially sectioned; D5,. representative section of submandibular gland. (E) LEFT NECK DISSECTION LEVEL II - An unoriented, tan-pink fragment of fibrofatty tissue (9.0 X 5.5 X 2.0 cm). Dissection. reveals 24 lymph nodes ranging from (0.1 X 0.1 X 0.1 cm to 3.0 X 1.5 X 1.0 cm). SECTION CODE: E1, six lymph nodes; E2, five lymph nodes; E3, three lymph nodes; E4, three lymph nodes; E5, two. lymph. nodes; E6, one lymph node, trisected; E7, one lymph node, serially sectioned; E8, one lymph node, trisected; E9, one. lymph node, trisected; E10, E11, one lymph node, serially sectioned. (F) LEFT NECK DISSECTION LEVEL III - An unoriented, tan-pink fragment or fibrofatty tissue (7.0 X 4.5 X 1.5 cm). Dissection. reveals 10 lymph nodes ranging from (0.3 X 0.2 X 0.2 cm to 2.5 X 2.0 X 1.5 cm). SECTION CODE: F1, four lymph nodes; F2, three lymph nodes; F3, two lymph nodes; F4, one lymph node, serially. sectioned. CLINICAL HISTORY. None given. SNOMED CODES. T-53000, M-80703. \"Some tests reported here may have been developed and performance characteristics determined b. Pathology and Laboratory Medicine. These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration.\". Released by:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"SCC\",\n    \"reasoning\": \"Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"",
      "predicted": "SCC",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: SCC. Site: Tongue. Histology: Invasive squamous cell carcinoma. This maps to TCGA SCC.",
      "idx": 457,
      "timestamp": "2026-01-24T13:29:56.319011"
    },
    {
      "sample_idx": 285,
      "input": "SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer cecum. GROSS DESCRIPTION. Received fresh labeled \"right colon\" is a previously. unopened 30 cm. segment of proximal right colon with. attached 19 cm. of distal ileum surfaced by smooth scabrous tan pink. serosa with a copious amount of attached mesocolon and mesentery. An unremarkable 3.9 cm. appendix averaging 0.5 cm. in diameter is. present. The proximal and distal margins measures 4.5 and 8.0 cm. in circumference respectively. On...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer cecum. GROSS DESCRIPTION. Received fresh labeled \"right colon\" is a previously. unopened 30 cm. segment of proximal right colon with. attached 19 cm. of distal ileum surfaced by smooth scabrous tan pink. serosa with a copious amount of attached mesocolon and mesentery. An unremarkable 3.9 cm. appendix averaging 0.5 cm. in diameter is. present. The proximal and distal margins measures 4.5 and 8.0 cm. in circumference respectively. On opening there is a well. circumscribed, 5.5 X 4.9 cm. rubbery white pink-red tumor. immediately distal to the ileocecal valve. A portion of tumor and a. portion of normal mucosa are submitted for tissue procurement as. requested. On sectioning, the tumor has a maximal thickness of 1.0. cm. and appears to extend into the muscularis and extend to within. 1.2 cm. of the inked serosal surface. The ileal mucosa is. unremarkable, tan-pink with regular folds and the walls average 0.5. cm. in thickness. A soft tan-pink colonic polyp is present. measuring 0.2 cm. in greatest dimension, 11 cm. distal to the main. tumor (see block 8) No additional mass lesion or abnormality is. identified. Multiple soft to slightly rubbery pale tan tissues in. keeping with lymph nodes measuring up to 1.3 cm. in greatest. dimension are recovered from the attached mesocolon and mesentery. entative sections are submitted in 17 blocks as labeled. BLOCK SUMMARY: 1 - Proximal and distal margins; 2 - tumor to inked. free radial serosal surface; 3, 4 - central tumor; 5 - tumor to ICV;. 6 - tumor to distal mucosa; 7 - random ileum; 8 - colon with small. polyp; 9 - random colon; 10 - appendix; 11-13 - ole lymph nodes;. 14-17 - one bisected lymph node per cassette. MICROSCOPIC DESCRIPTION. This right hemicolectomy specimen contains a moderately. differentiated adenocarcinoma of the cecum, involving the cecal side. of the ileocecal valve. Please see the template below: Histologic type: Adenocarcinoma. Histologic grade Moderately differentiated. Primary tumor (pT) : The tumor invades nearly the full thickness of. the muscularis propria, (pT2). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: The tumor measures 1.2 cm. from the inked serosal surface and 19 cm from the proximal margin. Vascular invasion: Negative. Regional lymph nodes (pN) : Twenty-four lymph nodes are found, all. Of which are negative for metastatic disease, 0/24 (pNO). Non-lymph node pericolonic tumor: Negative. Distant metastasis (pM) : Cannot be assessed. Other findings: A 2 mm adenomatous polyp is noted within the colon. Ileum and appendix, no significant pathology. DIAGNOSIS. Right colon, right hemicolectomy - Moderately-differentiated. adenocarcinoma. of the cecum extending into but not through the muscularis. propria. No. lymphatic invasion found and all twenty-four lymph nodes are. negative for. metastatic disease. All margins are negative for tumor. An. incidental. 2 mm adenomatous polyp is noted within the right colon. Terminal ileum and appendix, no significant pathology. End Of Report ---.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "COAD",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 285,
      "timestamp": "2026-01-24T13:29:56.319023"
    },
    {
      "sample_idx": 209,
      "input": "P.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nP.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF THE TOTAL TUMOR VOLUME AND IS. PRESENT ADMIXED WITH THE INVASIVE COMPONENT. F. THE DUCTAL CARCINOMA IN SITU (DCIS) IS PRESENT IN 12/22 SLIDES. G. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. H. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. DUCTAL CARCINOMA IN SITU (DCIS) IS 4.0 MM. FROM THE NEAREST ANTERIOR MARGIN, THE INVASIVE CARCINOMA IS GREATER THAN 1.0 CM FROM ALL. MARGINS. I. THE NIPPLE IS INVOLVED BY DUCTAL CARCINOMA IN SITU. J. SKIN IS NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST: INTRADUCTAL PAPILLOMA AND FIBROCYSTIC CHANGES WITH. FIBROADENOMATOID NODULES,. L. BIOPSY SITE CHANGES WITH FAT NECROSIS. M. METASTATIC CARCINOMA INVOLVING FOUR OF TWENTY-SIX LYMPH NODES (4/26). N. THE LARGEST METASTATIC FOCUS MEASURES 2.0 CM. O. EXTRACAPSULAR EXTENSION IS IDENTIFIED AND MEASURES 1 MM. P. THE INVASIVE TUMOR CELLS TESTED POSITIVE FOR ESTROGEN AND WEAKLY POSITIVE FOR. PROGESTERONE RECEPTORS AND NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. LASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2 5 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitolic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION;. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. Comedo. DCIS admixed with invasive carc\u00ednoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupled by in situ component 50 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: Distance of in silu disease to closest margin: 40 mm. LYMPH NODES POSITIVE: 4. LYMPH NODES EXAMINED: 26. METHOD(S) OF LYMPH NODE EXAMINATION: H/E levels. SIZE OF NODAL METASTASES: Diameter of largest lymph nodo metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Papillonia, FCD, Other: Fibroadenomatoid nodules. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGEST\u00c9RONE RECEPTORS: positive. HER2/NEU:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n```json",
      "predicted": "BRCA",
      "ground_truth": "BRCA",
      "correct": true,
      "reasoning": "Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.",
      "idx": 209,
      "timestamp": "2026-01-24T13:29:56.319035"
    },
    {
      "sample_idx": 1385,
      "input": "SLIDE DISPOSITION: DIAGNOSIS: A. Uterus, hysterectomy: High grade serous carcinoma is. identified. forming a mass (7.0 x 4.1 x 0.4 cm) circumferentially. involving the. endometrial cavity. The tumor invades 0. 4 cm into the. myometrium. (total myometrial thickness, 1.6 cm). The tumor does not. involve. the endocervix. Lymphovascular space invasion is. identified. The. margins are negative for tumor. B. Lymph nodes, right and left para-aortic,. lymphadenectomy : Multiple (6 of 9) lymph nodes posi...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSLIDE DISPOSITION: DIAGNOSIS: A. Uterus, hysterectomy: High grade serous carcinoma is. identified. forming a mass (7.0 x 4.1 x 0.4 cm) circumferentially. involving the. endometrial cavity. The tumor invades 0. 4 cm into the. myometrium. (total myometrial thickness, 1.6 cm). The tumor does not. involve. the endocervix. Lymphovascular space invasion is. identified. The. margins are negative for tumor. B. Lymph nodes, right and left para-aortic,. lymphadenectomy : Multiple (6 of 9) lymph nodes positive for metastatic. carcinoma,. consistent with endometrial primary. C. Ovary and fallopian tube, right, salpingo-. oophorectomy High. grade serous carcinoma forming an intraluminal cystic mass. involving. the right fallopian tube. The right ovary is atrophic. D. Ovary and fallopian tube, left, salpingo-oophorectomy: High. grade serous carcinoma involving the adnexal soft tissue. and. atrophic ovary. The left fallopian tube is unremarkable. E. Lymph nodes, right and left pelvic, lymphadenectomy: Multiple. (2 of 21) lymph nodes are positive for metastatic. carcinoma,. consistent with endometrial primary. F. Omentum, omentectomy: Negative for tumor. With available surgical materials, [AJCC (7th edition). pT3aN2]. PRELIMINARY FROZEN SECTION CONSULTATION. A. Uterus, hysterectomy : Serous carcinoma. The margins. are. negative for tumor. C. Ovary and fallopian tube, right, salpingo-. oophorectomy : Carcinoma involving the right fallopian tube. The right. ovary is. atrophic. D. Ovary and fallopian tube, left, salpingo-oophorectomy: Carcinoma involving the adnexal soft tissue and ovary. The left. fallopian tube is unremarkable. F. Omentum, omentectomy: Negative for tumor. HOLD to process lymph nodes on permanent sections. Frozen section histologic interpretation performed by: GROSS DESCRIPTION: A. Received fresh labeled \"uterus\" is a 123.0 gram uterus. with an. unremarkable cervix. The uterine serosa is smooth There. is a 7.0 x. 4.1 X 1.1 cm mass involving the entire endometrial cavity. and lower. uterine segment which grossly appears to invade 0.2 cm. into the 1.6. cm thick myometrium. Representative sections are. submitted. B. Received fresh labeled \"right and left para-aortic. nodes\" is a. 5. 4 X 4.5 x 1.9 cm aggregate of adipose tissue and lymph. nodes. All. lymph nodes submitted. C. Received fresh labeled \"right tube and ovary\" is a 2.0. x 1.4 X. 0.6 cm ovary with an 8.0 x 0.6 cm attached fallopian tube. with a 1.0. x 0.8 cm paratubal cyst. The ovary has a smooth outer. surface and a. solid cut surface. Representative sections submitted. D. Received fresh labeled \"left tube and ovary\" is a 2.5. x 1.2 x. 0.7 cm ovary with a 7.0 x 0.4 cm attached fallopian tube. The ovary. has a smooth outer surface and a solid cut surface. Representative. sections submitted. E. Received fresh labeled \"right and left pelvic lymph. nodes\" is a. 9.8 X 7. 4 X 1.2 cm aggregate of adipose tissue and lymph. nodes. All. lymph nodes submitted. F. Received fresh labeled \"dependent omentum\" is a 17.2 x. 13.0 x. 1.5 cm portion of omentum. No masses are identified. grossly. Lymph. nodes are not identified. Representative sections. submitted. BLOCK SUMMARY: Part A: Uterus. 1 Endometrial tumor. 2 Cervix. 3 Endocervix. 4 Endometrial tumor-2. 5 Endometrial tumor-3. 6 Endometrial tumor-4. 7 Endometrial tumor-5. Part B: Right and left para aortic lymph nodes. 1 Rt/Lt paraaortic LN 2 (B1). 2 Rt/Lt paraaortic LN 1 (B2). 3 Rt/Lt paraaortic LN 2 (B3). 4 Rt/Lt paraaortic fat- 1. 5 Rt/Lt paraaortic fat-2. 6 Rt/Lt paraaortic LN 1 (B4). Part C: Right tube and ovary. 1 Right fallopian tube. 2 Right ovary. Part D: Left tube and ovary. 1 Left fallopian tube. 2 Left ovary. 3 Left adnexal tissue. Part E: Right & left pelvic Lymph Nodes. 1 Pelvic LNs-! 5 (E1). 2 Pelvic LNs- - 2 (E2). 3 Pelvic LNs- - 5 (E3). 4 Pelvic LNs- - 2 (E4). 5 Pelvic LNs- - 3 (E5). 6 Pelvic LNs- - 2 (E6). 7 Pelvic LN-1 (E7). 8 Pelvic LN- 1 (E8). 9 Pelvic LNs- - 2 (E9). 10 Pelvic LNs - 4 (E10). 11 Pelvic LN-1 (E11). Part F: Dependent Omentum. 1 Dependent omentum.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UCEC\",\n    \"reasoning\": \"Initial code: UCEC. Site: Uterus. Histology",
      "predicted": "UCEC",
      "ground_truth": "UCEC",
      "correct": true,
      "reasoning": "Initial code: UCEC. Site: Uterus. Histology: Serous carcinoma. This maps to TCGA UCEC.",
      "idx": 1385,
      "timestamp": "2026-01-24T13:29:56.319047"
    },
    {
      "sample_idx": 1116,
      "input": "Clinical Diagnosis & History: year old with large right retroperitoneal sarcoma encasing vena cava. biopsy (+) leiomyosarcoma. Specimens Submitted: 1: SP: Abdominal leiomyosarcoma. DIAGNOSIS: 1. SOFT TISSUE, RETROPERITONEAL; RESECTION: -HIGH GRADE LEIOMYOSARCOMA INVLOVING WALL OF VENA CAVA. -TUMOR DIMENSIONS: 14 x 13 x 10 CM. FOCAL NECROSIS (LESS THAN 10%) IS PRESENT. -SURGICAL MARGINS (SOFT TISSUE AND VENA CAVA) ARE FREE OF TUMOR. FOCALLY TE TUMOR IS WITHIN 0.2 CM OF SOFT TISSUE MARGIN, HOWEVER...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nClinical Diagnosis & History: year old with large right retroperitoneal sarcoma encasing vena cava. biopsy (+) leiomyosarcoma. Specimens Submitted: 1: SP: Abdominal leiomyosarcoma. DIAGNOSIS: 1. SOFT TISSUE, RETROPERITONEAL; RESECTION: -HIGH GRADE LEIOMYOSARCOMA INVLOVING WALL OF VENA CAVA. -TUMOR DIMENSIONS: 14 x 13 x 10 CM. FOCAL NECROSIS (LESS THAN 10%) IS PRESENT. -SURGICAL MARGINS (SOFT TISSUE AND VENA CAVA) ARE FREE OF TUMOR. FOCALLY TE TUMOR IS WITHIN 0.2 CM OF SOFT TISSUE MARGIN, HOWEVER IS WELL. LIMITED BY FIBROUS MEMBRANOUS TISSUE AND ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh labeled \"abdominal leiomyosarcoma\" and. consists of an irregular soft tissue mass with dimensions of 16 x 14 x 11. cm. The specimen is covered by ragged fat, focal skeletal muscle, patches of. peritoneum, and a focal thin fibrous membrane. There is an adherent 9 cm. segment of vein with a diameter of 1 cm that is stapled at both ends. Sectioning reveals a well-circumscribed tumor with dimensions of 14 x 13. x. 10 cm. The tumor has a tan, rubbery, whorled cut surface with central. hemorrhage and white fibrous areas. No gross necrosis is identified. The. tumor appears to invade the surrounding fat with a pushing border. The tumor. is adherent to the large vessel but does not appear to extend to the entire. wall. The endothelial surface is tan and smooth. The tumor abuts the thin. SURGICAL. fibrous capsule. Gross photographs are taken, tissue is submitted for TPS,. and representative sections are submitted. Summary of sections: TP-tumor to peritoneum. TF-tumor to fibrous membrane. TM-tumor to muscle. TV-tumor to vessel. VM-vessel margins. T-tumor representative sections. Summary of Sections: Part 1: SP: Abdominal leiomyosarcoma. Block. Sect. Site. PCs. 10. T. 10. 1. TF. 1. 1. TM. 1. 1. TP. 1. 2. TV. 2. 1. VM. 2.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PRAD\",\n    \"reasoning\": \"Initial code: PR",
      "predicted": "PRAD",
      "ground_truth": "SARC",
      "correct": false,
      "reasoning": "Initial code: PRAD. Site: Abdominal. Histology: Leiomyosarcoma. This maps to TCGA PRAD.",
      "idx": 1116,
      "timestamp": "2026-01-24T13:29:56.319058"
    },
    {
      "sample_idx": 178,
      "input": "Final Diagnosis. A. Breast, left, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III). [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9] is identified forming a mass (4.8 x. 2.7 x 1.9 cm) located in the lower outer quadrant of the breast. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Lobular. carcinoma in situ is also present. All surgical resection margins, including the deep margin, are. n...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFinal Diagnosis. A. Breast, left, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III). [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9] is identified forming a mass (4.8 x. 2.7 x 1.9 cm) located in the lower outer quadrant of the breast. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Lobular. carcinoma in situ is also present. All surgical resection margins, including the deep margin, are. negative for tumor (minimum tumor free margin, 0.3 cm, deep margin and 0.5 cm, superficial. margin). With available surgical material, the AJCC staging is pT2NXMX (see comment). B. Breast, right, simple mastectomy: Benign nonproliferative breast parenchyma. C. Lymph nodes, left axillary, lymphadenectomy: Multiple (14) lymph nodes are negative for. tumor. D. Lymph nodes, left lowest axillary, lymphadenectomy: Fibroadipose tissue, negative for. tumor. No lymphoid tissue identified.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "BRCA",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 178,
      "timestamp": "2026-01-24T13:29:56.319069"
    },
    {
      "sample_idx": 1209,
      "input": "Case ID. 2. Gross. Microscopic Description. Diagnosis Details. Description. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Subtotal resection of stomach. Tumor site: Fundus. Tumor size: 6x5x4cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/12 positive for metastasis (Regional. 0/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not speci...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nCase ID. 2. Gross. Microscopic Description. Diagnosis Details. Description. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Subtotal resection of stomach. Tumor site: Fundus. Tumor size: 6x5x4cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/12 positive for metastasis (Regional. 0/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json",
      "predicted": "LUAD",
      "ground_truth": "STAD",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Stomach. Histology: Adenocarcinoma. This maps to TCGA LUAD.",
      "idx": 1209,
      "timestamp": "2026-01-24T13:29:56.319086"
    },
    {
      "sample_idx": 864,
      "input": "Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.9000000000000004. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2b. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. A...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.9000000000000004. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2b. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA",
      "predicted": "LUAD",
      "ground_truth": "LUSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Squamous carcinoma. This maps to TCGA LUAD.",
      "idx": 864,
      "timestamp": "2026-01-24T13:29:56.319097"
    },
    {
      "sample_idx": 65,
      "input": "BIOPSY OR SURGICAL SPECIMEN (Order. Patient Information. Provider Status. Component. Lab. FINAL PATHOLOGICAL DIAGNOSIS. A. Left distal ureter, radical cystoprostatectomy: Unremarkable urothelium; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. B. Right distal ureter, radical cystoprostatectomy: - Unremarkable urothellum; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. C. Bladder and prostate, radical cystoprostat...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nBIOPSY OR SURGICAL SPECIMEN (Order. Patient Information. Provider Status. Component. Lab. FINAL PATHOLOGICAL DIAGNOSIS. A. Left distal ureter, radical cystoprostatectomy: Unremarkable urothelium; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. B. Right distal ureter, radical cystoprostatectomy: - Unremarkable urothellum; no high grade dysplasia or carcinoma identified. - Frozen section diagnosis is confirmed. C. Bladder and prostate, radical cystoprostatectomy: - Invasive urothelial carcinoma with squamous differentiation, high grade. - Tumor invades perivesical tissue macroscopically (pT3b). - All surgical resection margins free of tumor. - Prostate with benign prostatic hyperplasia; no invasive carcinoma identified. - See CAP template below for full report. - See comment. D. Right Iliac lymph nodes, lymph node dissection: - Five benign lymph nodes identified, all negative for metastatic carcinoma. (0/5). E. Right obturator lymph nodes, lymph node dissection: - Three benign lymph nodes identified, all negative for metastatic carcinoma. (0/3). F. Left iliac lymph nodes, lymph node dissection: - Three benign lymph nodes identified, all negative for metastatic carcinoma. (0/3). G. Left obturator lymph nodes, lymph node dissection: - Ten benign lymph nodes identified, all negative for metastatic carcinoma. (0/10). CAP Cancer Template. Specimen: Bladder. Other (specify): Prostate. Procedure: Radical cystoprostatectomy. Tumor Site: Left lateral wall. Anterior wall. Posterior wall. Right ureteral orifice. Tumor Size: Greatest dimension: 4.5 cm. Histologic Type: Urothelial (transitional cell) carcinoma with squamous differentiation. Associated Epithelial Lesions: None identified. Histologic Grade: Urothellal Carcinoma (WHO 2004/ISUP): High-grade. Tumor Configuration: Solid/nodule. Flat. Ulcerated. Microscopic Tumor Extension: Invades perivesical tissue macroscopically (extravesical mass). Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 mm. Specify margin: Posterior soft tissue margin. Lymph-Vascular Invasion: Indeterminate. Pathologic Staging (pTNM): TNM Descriptors: m (multiple primary tumors). Primary Tumor (pT): pT3b: Macroscopically (extravesicular mass). Regional Lymph Nodes (pN): pNO: No lymph node metastasis. Specify: Number examined: 21. Number involved (any size): 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Urothelial dysplasia. Inflammation/regenerative changes. Ancillary Studies: None performed at this time; blocks C13 and C14 will be held for future studies. if necessary. The above pathology diagnosis incorporates data elements as outlined in the CAP. Cancer Protocols and Checklists which are based on the AJCC/UICC TNM, 7th. edition. DIAGNOSIS COMMENT. Selected slides were reviewed at the. on. and the diagnoses represent a consensus. opinion. \"Electronically Signed Out By. CLINICAL HISTORY. Bladder tumor. Radical cystectomy/ prostatectomy with lleal conduit. SPECIMEN(S) RECEIVED. A: Left distal ureter. B: Right distal ureter. C: Bladder and prostate. D: Right iliac lymph nodes. E: Right obturator lymph nodes. F: Left iliac lymph nodes. G: Left obturator lymph nodes. GROSS DESCRIPTION. Specimen A is received fresh for frozen section labeled with the patient's name. and designated \"left distal ureter\". The specimen consists of a segment of. ureter measuring 0.6 cm in diameter x 0.3 cm in length. Section key: A1 specimen is completely submitted for frozen section. Specimen B is received fresh for frozen section labeled with the patient's name. and designated \"right distal ureter\". The specimen consists of a segment of. ureter measuring 0.4 cm in diameter x 0.3 cm in length. Section key: B1 specimen is completely submitted for frozen section. Specimen C. Type of specimen: Urinary bladder, ureter stumps, prostate, seminal vesicles. The patient's name and case number on the specimen container match the. accompanying paperwork and cassettes. Procedure: Radical cystoprostatectomy. Fixative: Received fresh and later placed in formalin. Dimensions: Bladder: Superior to inferior 7.5 cm, right to left 6.0 cm, anterior to. posterior 3.5 cm. Right ureter stump: 1.0 cm in length and 0.5 cm in diameter; left 2.5 cm in. length and 0.5 cm in diameter. Prostate: Apex to base 3,8 cm, anterior to posterior 3.2 cm, right to left 5.0. cm. Description of findings: Tumor: Three distinct separate tumors are identified. The largest tumor. occupies the left lateral wail and extends to include portions of both the. anterior and posterior wall. In some areas, the tumor appears to abut the inked. posterior bladder surface. This tumor measures 4.5 x 3.6 cm. The central. portion of the tumor is rough, hemorrhagic, and somewhat shaggy and has a. somewhat necrotic appearance. The necrosis involves 80% of the surface of the. tumor. There are tan-gray, nodular, viable areas at the peripheral margin of. the tumor. On section, this tumor can be seen to deeply invade the bladder wall. and appears to have extended through the full thickness to involve the adjacent. perivesicular adipose tissue. The second tumor occupies a portion of the. posterior wall and extends laterally to surround the right ureteral orifice. This tumor measures 2.5 x 2.0 cm. The tumor is largely exophytic extending 0.9. cm above the lining of the bladder wall. The third tumor occupies a portion of. the Inferior anterior bladder wall and measures 1.7 x 1.5 cm and rises 0.6 cm. above the fining of the bladder wall. The lumen of the bladder contains a large. volume of form friable blood clot. The clot measures 7.0 x 7.0 x 2.5 cm. Uninvolved mucosa: The involved mucosa has a normal tan-gray appearance with no. additional lesions noted. Sectioning through the prostate reveals a normal. tan-gray, lobulated, spongy cut surface. Prostate, seminal vesicies and vasa deferentia: Ink code: Anterior: blue. Posterior: black. Right side: orange. Left side: blue. Section key: C1 en face urethral resection margins. C2 largest tumor of left lateral wall, anterior surface. C3 C8 largest tumor of left lateral wall and posterior surface. C9, C10 second tumor of right lateral wall. C11, C12 third tumor anterior wall. C13 left ureteral orifice. C14 right ureteral orifice. C15 right lateral wall. C16 section of dome. C17 C19 right prostate submitted distal to proximal. C20 C22 left prostate submitted distal to proximal. C23 right seminal vesicle and vas deferens. C24 left seminal vesicle and vas deferens. Specimen D is received in formalin labeled with the patient's name and. designated \"right illac lymph node\". The specimen consists of an aggregate of. yellow, fatty tissue measuring 5.0 x 4.3 x 2.5 cm. Multiple lymph nodes are. identified ranging in size from 0.5 cm up to 2.1 cm in greatest dimension. Section key: The lymph nodes are entirely submitted as follows: D1, D2 largest lymph node trisected. D3 two lymph nodes, bisected, one marked with ink. D4 two lymph nodes, bisected, one marked with ink. Specimen E is received in formalin labeled with the patient's name and. designated \"right obturator lymph node\". The specimen consists of an aggregate. of yellow, fatty tissue measuring 5.5 x 3.8 x 2.0 cm. Three lymph nodes are. identified ranging from 0.8 cm up to 3.5 cm in greatest dimension. Section key: The lymph nodes are entirely submitted as follows: E1 E3 largest lymph node trisected. E4, E5 one lymph node, bisected. E6 one single lymph node. Specimen F is received in formalin labeled with the patient's name and. designated \"left illac lymph node\". The specimen consists of an aggregate of. yellow, fatty tissue measuring 3.5 x 2.5 x 1.5 cm. Three lymph nodes are. identified ranging in size from 0.5 cm up to 1.5 cm in greatest dimension. Section key: F1 lymph nodes are completely submitted. Specimen G is received in formalin labeled with the patient's name and. designated \"left obturator lymph node\". The specimen consists of an aggregate. of yellow, fatty tissue measuring 4.5 x 4.0 x 2.3 cm. Multiple lymph nodes are. identified ranging from 0.2 cm up to 3.0 cm in greatest dimension. Section key: Lymph nodes are completely submitted as follows: G1, G2 largest lymph node bisected. G3 two lymph nodes, bisected, one marked with blue ink. G4, G5 multiple single lymph nodes. MICROSCOPIC DESCRIPTION. The stain quality is acceptable. A-G. The microscopic findings are reflected in the diagnoses rendered. INTRAOPERATIVE CONSULT DIAGNOSIS. Time in: Time out: AFS1, Left distal ureter: \"Negative for malignancy\". BFS1, Right distal ureter: \"Negative for malignancy\". Conveyed to. on. Interpretation performed at: Anatomic Pathology Report - Scan on. Result History. BIOPSY OR SURGICAL SPECIMEN. Transcription. Type. Author. Document Text. Display only: Transcription (. Date and Time. This order is currently not shared in. BIOPSY OR SURGICAL SPECIMENT. Patient Information. Visit Information. Time. Department. Provider. Urology. Admission Information. Attending Provider. Admitting Provider. Admission Type. Admission Date/Time. Discharge Date. Hospital Service. Auth/Cert Status. Service Area. Admission Status. Unknown Status (No Confirmation. Date and Time. Authorizing. Department. Urology. Code. BIOPSY OR SURGICAL SPECIMEN. Discharge Information. Discharge Provider. Date/Time. Disposition. Destination. (none). (none). (none). (none). Authorizing Provider. Encounter Provider. Anatomic Pathology Report - Scan. Date and Time. Priority and Order Details. Priority. Class. Routine.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Prostate. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UROS\",\n    \"reasoning\": \"Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TC",
      "predicted": "UROS",
      "ground_truth": "BLCA",
      "correct": false,
      "reasoning": "Initial code: UROS. Site: Bladder. Histology: Urothelial carcinoma with squamous differentiation. This maps to TCGA UROS.",
      "idx": 65,
      "timestamp": "2026-01-24T13:29:56.319109"
    },
    {
      "sample_idx": 61,
      "input": "De-Identified Specimen Code. / M. SPECIMEN SUBMITTED: Part A: LEFT DISTAL URETER. Part B: RIGHT DISTAL URETER. Part C: BLADDER/ PROSTATE. Part D: RIGHT PELVIC LYMPH NODES. Part E: LEFT PELVIC LYMPH NODES. Final Diagnosis. 1. Left and right distal ureters, biopsy (A, B) - Negative for neoplasm. 2. Bladder, excision (C) - Invasive poorly differentiated urothelial carcinoma with invasion through. muscular wall and involvement of perivesical adipose tissue. 3. Prostate, excision (C) - Glandular hype...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nDe-Identified Specimen Code. / M. SPECIMEN SUBMITTED: Part A: LEFT DISTAL URETER. Part B: RIGHT DISTAL URETER. Part C: BLADDER/ PROSTATE. Part D: RIGHT PELVIC LYMPH NODES. Part E: LEFT PELVIC LYMPH NODES. Final Diagnosis. 1. Left and right distal ureters, biopsy (A, B) - Negative for neoplasm. 2. Bladder, excision (C) - Invasive poorly differentiated urothelial carcinoma with invasion through. muscular wall and involvement of perivesical adipose tissue. 3. Prostate, excision (C) - Glandular hyperplasia. -Chronic inflammation. 4. Seminal vesicles, right and left, excision (C) - Negative for neoplasm. 5. Right pelvic lymph nodes, excision (D) - Negative for neoplasm, ten lymph nodes. 6. Left pelvic lymph nodes, excision (E) - Negative for neoplasm, ten lymph nodes. Diagnosis Comment: 2. Specimen Type: Radical cystoprostatectomy. Tumor Size, Greatest dimension: 3.0 cm. Histologic Type: Urothelial carcinoma with glandular and squamous differentiation. Urothelial Carcinoma: (WHO/ISUP, 1998) High-grade. Associated Epithelial Lesions: High-grade papillary urothelial carcinoma in previous biopsy specimen. Margins: Margins uninvolved by invasive cancer. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Direct Extension of Invasive Tumor: Perivesical fat. Other Diagnoses: See above. Pathologic Stage: Primary Tumor: (pT). pT3b: Macroscopically invades perivesical fat (extravesical mass). Regional Lymph Nodes: (pN). pNO: No regional lymph node metastasis. Distant Metastasis (pM): pMX: Cannot be assessed. Clinical Diagnosis: BLADDER CA. Gross Description: A. Received fresh at the frozen desk is a specimen labeled \"left distal ureter\" consisting of one piece of. luminal tissue measuring 1 x 1 x 0.5 cm. The specimen is unoriented. The specimen is bisected and. totally submitted for frozen section as A1. B. Received fresh at the frozen desk is a specimen labeled \"right distal ureter\" consisting of one piece. of unoriented luminal tissue measuring 1 x 0.5 x 0.5 cm. The specimen is bisected and totally. submitted for frozen section as B1. C. Received in formalin labeled \"bladder and prostate\" is a specimen consisting of a urinary bladder with. attached prostate and seminal vesicles. The bladder measures 11 x 10 X 4 cm. The exterior surface of. the bladder is covered by fibroadipose tissue and is inked black. After the bladder is opened, a polypoid. mass measuring 0.7 x 0.6 x 0.6 cm is identified in the left posterior inferior wall of the bladder 0.2 cm. from the left ureter. On sectioning, the mass extends through the muscularis into the surrounding. adipose tissue but appears to be 0.4 cm from soft tissue margin (inked black). The tumor portion. involving the bladder wall has the following dimensions: 3 x 1.5 x 1.5 cm. The remaining bladder. mucosa is slightly edematous. A segment of right ureter is 1 cm. It is patent with unremarkable. mucosa. A segment of left ureter is 1 cm. Its mucosa is roughened, but it is patent. The prostate. measures 3.5 cm transversely, 3 cm anteroposteriorly, and 3 cm craniocaudally. The capsular surface. is smooth. The gland is inked blue on the right, and yellow on the left. The gland is sectioned from apex. to base transversely at 3 mm intervals perpendicular to the urethra. The cross sections do not reveal a. mass lesion. Rubbery nodularity is not present. The seminal vesicles are unremarkable. Sections are. submitted as follows: C1 right ureteric margin, C2 left ureteric margin, C3 urethral margin, C4 tumor with. deepest extension, C5-C8 tumor involving bladder wall, C9 left ureter, C10 right ureter, C11 posterior. bladder wall, C12 right bladder wall, C13 left bladder wall, C14 bladder dome, C15 bladder trigone, C16. right apex of the prostate, C17 left apex of the prostate, C18 right mid portion of the prostate at 9 mm,. C19 left mid portion of the prostate at 9 mm, C20 right base of the prostate with right seminal vesicle,. C21 left base of the prostate, C22 left seminal vesicle, C23 anterior bladder wall. D. Received fresh labeled \"right pelvic lymph node\" are multiple irregular segments of fibroadipose. tissue aggregating to 6.0 x 4.0 x 1.0 cm. Palpation reveals 10 tan-pink firm nodules resembling lymph. nodes ranging in size from 0.7 to 5.0 cm in greatest dimension. The nodules are totally submitted in. formalin as follows: D1 two nodules; D2 two nodules; D3 two nodules; D4 two nodules; D5 one nodule;. D6-D9 largest nodule, serially sectioned, totally submitted. E. Received fresh labeled \"left pelvic lymph nodes\" are multiple irregular segments of fibroadipose. tissue aggregating to 6.0 x 5.5 x 1.5 cm. Palpation reveals 17 tan-pink firm nodules resembling lymph. nodes ranging in size from 0.2 to 6.0 cm in greatest dimension. The nodules are totally submitted in. formalin as follows: E1 four nodules; E2 four nodules; E3 four nodules; E4 two nodules; E5 one nodule. bisected, totally submitted; E6 one nodule; E7-E11 largest nodule, sectioned, totally submitted.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"UBLC\",\n    \"reasoning\": \"Initial code: UBLC. Site: Bladder. Histology: Urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA UBLC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"BLCA\",\n    \"reasoning\": \"Initial code: BLCA. Site",
      "predicted": "BLCA",
      "ground_truth": "BLCA",
      "correct": true,
      "reasoning": "Initial code: BLCA. Site: Bladder. Histology: Invasive urothelial carcinoma with glandular and squamous differentiation. This maps to TCGA BLCA.",
      "idx": 61,
      "timestamp": "2026-01-24T13:29:56.319121"
    },
    {
      "sample_idx": 191,
      "input": "Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: A single lymph node is. negative for malignancy. B. Breast, left, excisional biopsy: Invasive lobular carcinoma,. Nottingham grade 2. Note: The margins are negative for malignancy. C. Breast, posterior lateral margin, biopsy: Focal lobular carcinoma. in situ, negative for invasive carcinoma. Microscopic Description: A. A single lymph node is negative for malignancy. [At the request of some staff o...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFinal Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: A single lymph node is. negative for malignancy. B. Breast, left, excisional biopsy: Invasive lobular carcinoma,. Nottingham grade 2. Note: The margins are negative for malignancy. C. Breast, posterior lateral margin, biopsy: Focal lobular carcinoma. in situ, negative for invasive carcinoma. Microscopic Description: A. A single lymph node is negative for malignancy. [At the request of some staff oncologists and in keeping with the. opinion of some experts in breast pathology, immunohistochemical stains. for keratin were not used on the sentinel lymph node sections in this. case. These stains can be obtained if desired. Our paraffin blocks. are retained for 10 years. (Weaver DL et al. New Engl J Med 364:412,. 2011. Schwartz GF et al. Cancer 94(10):2542,. B. Invasive carcinoma: Histologic type: Invasive lobular carcinoma. Nottingham grade: 2. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Mitotic index: 0 mitoses/ 10 HPFs (1 HPF = 1.96 sq. mm). Tumor size: 1.7 cm. Specimen margins: Negative for malignancy. Carcinoma is 1.2 mm. from the red (anterior) inked margin in block B15. Vessel invasion: Absent. Calcification: Absent. Non-tumorous breast: Fat necrosis, compatible with prior biopsy site. pTNM stage: Tlc NO. Prognostic markers: No previous biopsy here. Markers are available if. needed. Antibody Results Comment. CK5/6. Positive. E-cadherin. Positive. C. Lobular carcinoma in situ is present. Antibody Results Comment. E-cadherin. Negative. Paraffin sections; 10% neutral buffered formalin; Controls stain. appropriately. (A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and controlled in our laboratory and. their performance for. in vitro diagnosis is well described in the medical literature. They have not been cleared. or approved by the FDA.]. Specimen. A. Left axillary sentinel node. B. Left breast biopsy long anterior short superior. C. Posterior lateral margin long anterior short superior. Clinical Information. Cancer diagnosed in. Gross Description. A. Specimen A. is received unfixed labeled axillary sentinel node and. consists of 3 pieces of yellow soft tissue measuring 2.5 x 2 x 1 2.5. x. 1.7 x 1.4 and 2.2 x 1 x 0.5 cm. Sections after fixation. AS-6. B. The specimen is received unfixed in the Transpec container labeled. left breast biopsy and consists of yellow and red piece of soft tissue. measuring 8.5 by 6 by approximately 2.5 cm. The external surface the. specimen is inked as indicated below. Anterior: Red. Posterior Orange. Lateral: Blue. Medial: Green. Superior: Yellow. Inferior: Black. There is a firm area near one end of the specimen measuring 1.5 by 1.7. cm in greatest dimension. A small portion of the tumor is taken for. research purposes. Sections after fixation. RS-16. Specimen C. is received unfixed labeled posterior lateral margin and. consists of a yellow piece of soft tissue measuring 3.4 x 2.5 x 1.5 cm. There is along the short suture on the specimen. The external surface. of the specimen is inked as indicated below. Anterior: Red. Posterior: Orange. Lateral: Blue. Medial: Green. Superior: Yellow. Inferior: Black. Sections after fixation.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "BRCA",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 191,
      "timestamp": "2026-01-24T13:29:56.319132"
    },
    {
      "sample_idx": 447,
      "input": "Gross Description: A. \"Left deep tongue margin.\" 3 fragments of red-tan tissue, each 0.5 cm. All. processed for frozen section. Frozen section control, All processed, A1. B. \"Left tongue (suture towards tongue base).\". Microscopic Description: Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 X 3.0 x 2.0 cm. Laterality: Left. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nGross Description: A. \"Left deep tongue margin.\" 3 fragments of red-tan tissue, each 0.5 cm. All. processed for frozen section. Frozen section control, All processed, A1. B. \"Left tongue (suture towards tongue base).\". Microscopic Description: Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 X 3.0 x 2.0 cm. Laterality: Left. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic type: Squamous cell carcinoma, conventional. Histologic grade: Grade 1. Margins: Uninvolved by invasive or in-situ carcinoma. Lymph-vascular invasion: Absent. Perineural invasion: Absent. Stage: pT2 NO. SUBMANDIBULAR GLAND (LEFT): UNREMARKABLE. LYMPH NODES (LEFT NECK, LEVEL 1): NO NEOPLASM (2 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 2): NO NEOPLASM (7 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 3): NO NEOPLASM (35 NODES EXAMINED). LYMPH NODES (LEFT NECK, LEVEL 4): NO NEOPLASM (18 NODES EXAMINED). Diagnosis Details: Tongue (Base, left side): Invasive keratinizing squamous cell carcinoma. Comments: The largest lymph node is 2.2 cm. It has been entirely processed. It exhibits marked follicular. hyperplasia, but there is no metastatic neoplasm. Formatted Path Reports: HEAD & NECK CHECKLIST. Procedure: Resection, partial glossectomy. Specimen integrity: Intact. Specimen size: 4.0 x 3.0 x 2.0 cm. Tumor site: Base of tongue. Tumor focality: Single focus. Tumor size: 2.3 cm greatest dimension. Tumor thickness: 1.0 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Margins: Uninvolved by invasive or in-situ carcinoma. Lymph-vascular invasion: Absent. Perineural invasion: Absent. Laterality: Left.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 447,
      "timestamp": "2026-01-24T13:29:56.319144"
    },
    {
      "sample_idx": 476,
      "input": "Specimen(s) Received. 1. Nck: RT. perifacial node. 2. Neck: contents right neck - reg. 3. Neck: right hemiglossectomy (short stitch = anterior/ long stitch = medial) - reg. 4. Soft-Tissue: deep margin tongue. Diagnosis. 1. Right perifacial node: - One lymph node, negative for malignancy (0/1). 2. Right neck, dissection: - Metastatic squamous cell carcinoma involving three of forty-four lymph nodes (3/44). a. All involved nodes are level III. b. Largest node involved: 1.8 cm. C. Extracapsular ext...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nSpecimen(s) Received. 1. Nck: RT. perifacial node. 2. Neck: contents right neck - reg. 3. Neck: right hemiglossectomy (short stitch = anterior/ long stitch = medial) - reg. 4. Soft-Tissue: deep margin tongue. Diagnosis. 1. Right perifacial node: - One lymph node, negative for malignancy (0/1). 2. Right neck, dissection: - Metastatic squamous cell carcinoma involving three of forty-four lymph nodes (3/44). a. All involved nodes are level III. b. Largest node involved: 1.8 cm. C. Extracapsular extension present. Submandibular gland with mild chronic inflammation, negative for malignancy. 3. Right tongue, hemiglossectomy: - Squamous cell carcinoma, poorly differentiated. a. Maximal tumour dimension: 4.0 cm. b. Tumour thickness: 2.3 cm. c. Perineural invasion present. d. Invasive carcinoma seen focally very close (0.2 cm) to the medial margin. e. Severe squamous dysplasia/carcinoma in-situ (CIS) seen focally close (0.3 cm) to the inferior/lateral margin. f. All other margins negative for malignancy (> 0.5 cm). 4. Deep margin tongue: - Negative for malignancy. Synoptic Data. Specimen Type: Resection:Righ hemiglossectomy. Tumor Site: Tongue. Histologic Type: Squamous cell carcinoma, conventional. Tumor Size: Greatest dimension: 4.0 cm. Tumor thickness: 2.3 cm. Histologic Grade: G3: Poorly differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Absent. Perineural Invasion: Present. Additional Pathologic Findings: Carcinoma in situ. Margins: Margins uninvolved by tumor. Margins uninvolved by tumor - Distance of tumor from closest margin: 0.2 cm. Margins: medial. Pathologic Staging (pTNM): pT3: Tumor or lip or oral cavity more than 4 cm in greatest dimension. pN2b: Metastasis in multiple lipsilateral lymph nodes, none more than 6 cm in greatest. dimension for all aerodigestive sites except nasopharynx. Number of regional lymph nodes examined: 44. Number of regional lymph nodes involved: 3. Extra-capsular extension of nodal tumor: Present. pMX: Distant metastasis cannot be assessed. Gross Description. 1. The specimen is labeled with the patient's name and as \"NCK: RT perifacial node\". It consists of a lymph node that. measures 0.9 X 0.8 X 0.5 cm. 1A bisected and submitted in toto. 2. The specimen labeled with the patient's name and as \"neck: Contents right neck -- reg\" consists of an unoriented neck. dissection with overall dimensions of 13.5 cm SI x 6.0 cm AP x 2.5 cm ML. There is no suture orientation; the specimen. grossly appears to include right levels I, II, III and IV, as approximated utilizing the position of the submandibular gland. The internal jugular vein and the sternocleidomastoid muscle are absent. The submandibular gland measures 3.5 x 2.2 x. 2.0 cm and is unremarkable. Multiple lymph nodes ranging from 0,2 to 1.8 cm are identified in multiple levels. Representative sections are submitted. 2A submandibular gland. 2B level I, two lymph nodes. 2C level II, two lymph nodes. 2D-2F level III, one bisected lymph node per block. 2G level III, two lymph nodes. 2H level III, three lymph nodes. 21 level III, four lymph nodes. 2J level III, five lymph nodes. 2K level IV, one bisected fymph node. 2L level IV, three lymph nodes. 2M-2N level IV, four lymph nodes per block. 20-2P level IV, five lymph nodes per block. 3. The specimen is labeled the patient's name and as \"neck: Right hemiglossectomy (short stitch = anterior/long stitch =. medial)- reg\". It consists of a portion of right tongue measuring 6.5 cm AP x 3.4 cm SI X 3.5 cm ML. There is short. anterior, long medial suture orientation. There is a firm tumor involving the lateral and dorsal surf\u00e1ces of the tongue. The. tumor measures 4.0 cm AP x 3.7 cm SI x 2.3 cm ML. The tumor is pale and well delineated, and ulcerates the lateral. mucosal tongue surface. It grossly appears to involve the lateral mucosal margin, is 0.4 cm from the medial margin,. appears to involve the dorsal mucosal margin, is 0.2 cm from the inferior margin, 0.8 cm from the anterior margin, and 0.7. from the posterior margin. The remaining tongue mucosa has white plaques extending postero-superiorly from the tumor. These plaques measure 1.0 cm AP x 1.0 cm SI in aggregate. The surgical margins are painted with silver nitrate; superior. margins are over coated with green dye. The tumor (four pieces) and normal tissue are sampled for tissue banking. Representative sections are submitted. 3A anterior margin. perpendicular section. 3B-31 tumor sampled from anterior to posterior, each pair of blocks a full thickness section, bisected, with the superior. aspect in the first of each pair and the inferior aspect in the second of each pair. 3J mucosal plaques postero-superior to tumor. 3K posterior margin, perpendicular section. 4. The specimen is labeled with the patient's name and as \"soft tissue: Deep margin tongue QS\". It consists of a fragment. of tissue measuring 1.1 X 1.0 x 0.9 cm. The specimen is bisected and submitted in toto for frozen section. The specimen. is subsequently submitted in toto for research. 4A. frozen. section control submitted in toto for research. Quick Section Diagnosis. 4A. Deep tongue margin: negative for malignancy.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LU",
      "predicted": "LUAD",
      "ground_truth": "HNSC",
      "correct": false,
      "reasoning": "Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.",
      "idx": 476,
      "timestamp": "2026-01-24T13:29:56.319155"
    },
    {
      "sample_idx": 1034,
      "input": "MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A). LEFT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OF THIRTEEN LYMPH NODES. LESS THAN 1.0 MM FOCUS. NO EXTRANODAL EXTENSION PRESENT. (1/13). (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: Twenty one lymph nodes, no tumor present (0/21). (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTIO...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nMODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A). LEFT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: METASTATIC ADENOCARCINOMA IN ONE OF THIRTEEN LYMPH NODES. LESS THAN 1.0 MM FOCUS. NO EXTRANODAL EXTENSION PRESENT. (1/13). (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES: Twenty one lymph nodes, no tumor present (0/21). (C) PROSTATE AND SEMINAL VESICLES: Supplemental report to follow. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT EXTERNAL/ INTERNAL ILIAC HYPOGASTRIC AND OBTURATOR LYMPH NODES - Multiple fragments of fatty tissue. measuring in aggregate 9.0 x 7.0 x 1.5 cm. Dissection reveals multiple possible lymph nodes ranging from 0.6 up to 2.0 cm in their. greatest dimension. Possible lymph nodes are entirely submitted. SECTION CODE: A1, three possible lymph nodes; A2, three possible lymph nodes; A3, one sectioned possible lymph. node; A4, one sectioned possible lymph node; A5, one sectioned possible lymph node; A6, one sectioned possible lymph node;. A7, one sectioned possible lymph node; A8, one sectioned possible lymph node; A9, one sectioned possible lymph node; A10,. A11, one sectioned possible lymph node; A12, A13, one sectioned possible lymph node. (B) RIGHT EXTERNAL/ INTERNAL ILIAC, HYPOGASTRIC AND OBTURATOR LYMPH NODES - Multiple fragments of fatty. tissue. measuring in aggregate, 9.0 x 8.0 x 2.0 cm. Dissection reveals multiple possible lymph nodes ranging from 0.5 up to 2.5 cm. in their greatest dimension. Possible lymph nodes are entirely submitted in cassettes B1, five possible lymph nodes; B2, five. possible lymph nodes; B3, five possible lymph nodes; B4, four possible lymph nodes; B5, three possible lymph nodes; B6, one. sectioned possible lymph node; B7, one sectioned possible lymph node; B8, one sectioned possible lymph node; B9, one. sectioned possible lymph node; B10, one sectioned possible lymph node; B11, B12, one sectioned possible lymph node; B13, B14,. one sectioned possible lymph node. (C) PROSTATE AND SEMINAL VESICLES - Supplemental report to follow. CLINICAL HISTORY. None given. SNOMED CODES. \"Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration.\". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 2. Page: 3. ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (C) PROSTATE AND SEMINAL VESICLES: PROSTATIC ADENOCARCINOMA, GLEASON SCORE 7 (4+3) WITH TERTIARY GLEASON GRADE 5. COMPONENT. (SEE COMMENT). TUMOR INVADING INTRAPROSTATIC PORTION OF RIGHT SEMINAL VESICLE. TUMOR INVADING FOCALLY RIGHT BLADDER NECK. MARGINS OF RESECTION FREE OF TUMOR. VASCULAR/LYMPHATIC INVASION PRESENT. Left seminal vesicle and segments of vasa deferentia, no tumor present. SEE PREVIOUS REPORT FOR DIAGNOSIS OF PELVIC LYMPH NODES. COMMENT. The prostate gland contains a single focus of prostatic adenocarcinoma. The tumor is located in the right anterolateral, right lateral,. right posterolateral, right posterior, mid posterior, left posterior, left posterolateral and left lateral peripheral zone. The tumor focus. measures. 3.0. x2. cm. in the largest cross-sectional dimension and it is present in three cross sections and extensively in the apex. and. base. regions. The tumor invades focally the right bladder neck. The tumor invades focally the intraprostatic portion of the right. seminal vesicle. The margins of resection are free of tumor. Please refer to the previous report for the diagnosis of the pelvic lymph nodes. GROSS DESCRIPTION. (C) PROSTATE AND SEMINAL VESICLES - A prostate, attached right and left seminal vesicles and attached segments of right. and left vasa deferentia. The prostate gland (3.5 x 2.0 x 4.8 cm, 42 gm, postfixation) has the usual shape. The soft tissue present along the left. posterolateral aspects of the prostate appears more abundant than along the right side. A nodule is palpated on the right base. region. Blue ink is applied to surfaces of the prostate (anterior apex and under flap on left posterior surface) which do not represent. the true margin of resection. SECTION CODE: C1-C3, right seminal vesicle and segment of right vas deferens from the base towards the tip; C4-C6,. left seminal vesicle and segment of left vas deferens from the base towards the tip; C7, C8, prostatic base right border; C9-C11,. Page : 4. prostatic base right posterior border; C12-C19, prostatic base central portion; C20-C22, prostatic base left border; C23-C25,. prostatic base left posterior border; C27-C29, apex anterior; C30, C31, apex left; C32, C33, apex posterior; C34, C35, apex right;. C36, C37, detached portions from margin of resection according to specimen radiograph; C38-C49, sections of the three cross. sections of the prostate according to specimen radiograph. The anterior aspect of the prostate is inked ink green, left surface in red, right surface in yellow and posterior surface in. black. Blue. ink (23-29, 42, 43 and 46) and orange ink (C38, 41, 44-47 and 49) denote surfaces that do not represent the true. margin of resection. SNOMED CODES. Entire report and diagnosis completed by:\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\nThe initial code is PCPG. The site is prostate, and the histology is prostatic adenocarcinoma. This matches the TCGA PCPG code.\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"PCPG\",\n    \"reasoning\": \"Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.\"\n}\n```\n```json\n{\n    \"",
      "predicted": "PCPG",
      "ground_truth": "PRAD",
      "correct": false,
      "reasoning": "Initial code: PCPG. Site: Prostate. Histology: Prostatic adenocarcinoma, Gleason Score 7 (4+3) with tertiary Gleason Grade 5. This maps to TCGA PCPG.",
      "idx": 1034,
      "timestamp": "2026-01-24T13:29:56.319167"
    },
    {
      "sample_idx": 1232,
      "input": "FINAL DIAGNOSIS. PART 1: LYMPH NODE, CENTRAL COMPARTMENT, SELECTIVE DISSECTION. A. METASTATIC CARCINOMA IN TWO OUT OF SIX LYMPH NODES (2/6). B. NO EXTRANODAL EXTENSION. PART 2: THYROID, TOTAL THYROIDECTOMY (17 GRAMS). A. PAPILLARY THYROID CARCINOMA, TWO.FOCI (1.2 CM AND 0.5 CM),. B. LARGEST FOCUS: LEFI LOBE, TALL CELL VARIANT WITH EXTRATHYROID EXTENSION; TUMOR. LESS THAN 0.1 CM FROM THE MARGIN. C. CHRONIC LYMPHOCYTIC THYROIDITIS. D. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). E. PATHOLOGIC STAGE: p...",
      "prompt": "Review the pathology report and provide an immediate TCGA code.\n\n**Step 1 - Initial Code**: Based on your first read, state the single best TCGA code.\n**Step 2 - Evidence**: Justify the code with site and histology evidence.\n\nValid Codes:\nACC, BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, MESO, OV, PAAD, PCPG, PRAD, READ, SARC, SKCM, STAD, TGCT, THCA, THYM, UCEC, UCS, UVM\n\nProvide your response in JSON format. Follow the format of these two examples and give the output strictly in the json format.\n\nExample 1: Initial BRCA, then justification\n```json\n{\n    \"cancer_type\": \"BRCA\",\n    \"reasoning\": \"Initial code: BRCA. Site: Breast. Histology: Invasive ductal carcinoma. This maps to TCGA BRCA.\"\n}\n```\n\nExample 2: Initial LUAD, then justification\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n\nPathology report:\n\"\"\"\nFINAL DIAGNOSIS. PART 1: LYMPH NODE, CENTRAL COMPARTMENT, SELECTIVE DISSECTION. A. METASTATIC CARCINOMA IN TWO OUT OF SIX LYMPH NODES (2/6). B. NO EXTRANODAL EXTENSION. PART 2: THYROID, TOTAL THYROIDECTOMY (17 GRAMS). A. PAPILLARY THYROID CARCINOMA, TWO.FOCI (1.2 CM AND 0.5 CM),. B. LARGEST FOCUS: LEFI LOBE, TALL CELL VARIANT WITH EXTRATHYROID EXTENSION; TUMOR. LESS THAN 0.1 CM FROM THE MARGIN. C. CHRONIC LYMPHOCYTIC THYROIDITIS. D. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). E. PATHOLOGIC STAGE: pT3a N1. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Thyroid cancer. PROCEDURE: Total thyroidectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION THERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.2 cm. HISTOLOGIC TYPE: Papillary carcinoma. TNM DESCRIPTORS: m. PRIMARY TUMOR (pT): REGIONAL LYMPH NODES (pN): pN1a. Number of regional lymph nodes examined: 6. Number of regional lymph nodes involved: 2. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 0.1 mm. LYMPH-VASCULAR INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: CHRONIC LYMPHOCITIC THYROIDITIS.\n\"\"\"\n\nResponse:\n",
      "system_prompt": "You are an expert pathologist specializing in cancer classification.\nYour goal is to identify the specific TCGA Cancer Type Code (e.g., BRCA, LUAD) from the pathology report.\nThink rationally and explain your reasoning step-by-step.",
      "response": "```json\n{\n    \"cancer_type\": \"THCA\",\n    \"reasoning\": \"Initial code: THCA. Site: Thyroid. Histology: Papillary thyroid carcinoma. This maps to TCGA THCA.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"ACC\",\n    \"reasoning\": \"Initial code: ACC. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA ACC.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site: Lung. Histology: Adenocarcinoma with glandular features. This maps to TCGA LUAD.\"\n}\n```\n```json\n{\n    \"cancer_type\": \"LUAD\",\n    \"reasoning\": \"Initial code: LUAD. Site:",
      "predicted": "THCA",
      "ground_truth": "THCA",
      "correct": true,
      "reasoning": "Initial code: THCA. Site: Thyroid. Histology: Papillary thyroid carcinoma. This maps to TCGA THCA.",
      "idx": 1232,
      "timestamp": "2026-01-24T13:29:56.319178"
    }
  ],
  "end_time": "2026-01-24T13:29:56.336549",
  "duration_seconds": 208.385264
}